Dermatophytosis

AB1_DERMATOPHYTOSIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B35 Hospital discharge: ICD-9 — 110 Hospital discharge: ICD-8 — 110 Cause of death: ICD-10 — B35 Cause of death: ICD-9 — 110 Cause of death: ICD-8 — 110 2 out of 7 registries used, show all original rules.	6833
4. Check minimum number of events None	6833
5. Include endpoints None	6833
6. Filter based on genotype QC (FinnGen only)	6171

Control definitions (FinnGen only)

Control exclude: AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_DERMATOPHYTOSIS
CONTROL_EXCLUDE	AB1_MYCOSES
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B35
HD_ICD_9	110
HD_ICD_8	110
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B35
COD_ICD_9	110
COD_ICD_8	110
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Dermatophytosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	36369	15440	20714
Only index persons	32219	13723	18496
Unadjusted period prevalence (%)
Whole population	0.52	0.44	0.58
Only index persons	0.62	0.50	0.71
Median age at first event (years)
Whole population	54.08	55.94	52.65
Only index persons	53.56	55.39	52.20

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6171	2719	3452
Unadjusted period prevalence (%)	1.31	0.97	1.58
Median age at first event (years)	59.08	57.49	60.33

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6354: Matched controls
63540

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

B35.2

ICD-10 Finland

Tinea manuum

54.1

315.0

179

D01BA02

ATC

terbinafine; oral

6.2

307.7

3625

11194

L30.9

ICD-10 Finland

Dermatitis, unspecified

3.3

307.7

2127

8447

D01AE15

ATC

terbinafine; topical

4.9

307.7

1034

2426

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

3.5

307.7

2416

9471

E0000UV, ,

ATC

2.8

307.7

3414

18805

B35.1

ICD-10 Finland

Tinea unguium

21.2

307.7

2671

2105

TQW80

NOMESCO Finland

Local dermatologic skincare

8.1

307.7

521

697

D01AE16

ATC

amorolfine; topical

4.5

307.7

1506

4100

B35.4

ICD-10 Finland

Tinea corporis

17.9

307.7

489

295

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

15.4

307.7

753

551

B35.3

ICD-10 Finland

Tinea pedis

36.5

307.7

2584

1170

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.8

306.3

1083

3263

D07AC01

ATC

betamethasone; topical

2.6

295.0

3036

16553

B35.9

ICD-10 Finland

Dermatophytosis, unspecified

13.1

197.7

190

149

11006

ICD-8 Finland

Dermatophytosis, Pedis

+∞

187.4

179

XQ848

NOMESCO Finland

Dermatological photography

5.1

182.6

398

818

L30.3

ICD-10 Finland

Infective dermatitis

4.7

179.9

439

992

A46

ICD-10 Finland

Erysipelas

2.5

178.8

1354

6143

J02AC02

ATC

itraconazole; systemic

2.5

175.9

1397

6475

B35.8

ICD-10 Finland

Other dermatophytoses

21.4

173.8

130

D07AD01

ATC

clobetasol; topical

2.5

172.6

1391

6485

D07XC01

ATC

betamethasone; topical

2.6

163.3

1081

4580

B35.0

ICD-10 Finland

Tinea barbae and tinea capitis

80.0

148.1

E000001, ,

ATC

2.2

142.8

1458

7460

D07AC13

ATC

mometasone; topical

2.0

142.2

2089

12283

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.7

139.9

463

1308

D01AC02

ATC

miconazole; topical

2.9

139.1

701

2564

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

129.5

2078

12523

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

125.8

1068

5030

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.3

121.8

1036

4877

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.7

114.5

703

2840

D02AE01

ATC

carbamide; topical

2.9

107.0

536

1944

J01DB01

ATC

cefalexin; oral

2.2

106.9

5366

45446

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.1

106.7

303

766

L30.4

ICD-10 Finland

Erythema intertrigo

5.8

106.1

197

349

R4180

NOMESCO Finland

Podiatric therapy

6.1

105.5

185

310

H02AB06

ATC

prednisolone; systemic

1.8

104.2

3159

22798

L57.0

ICD-10 Finland

Actinic keratosis

2.3

100.1

843

3930

D07AB08

ATC

desonide; topical

2.3

99.3

816

3763

D07BC01

ATC

betamethasone and antiseptics; topical

2.2

97.7

904

4381

L85.89

ICD-10 Finland

Other specified epidermal thickening

22.1

97.6

B35

ICD-10 Finland

Dermatophytosis

8.1

97.1

131

165

D05AX52

ATC

calcipotriol, combinations; topical

2.9

95.0

482

1758

D05BB02

ATC

acitretin; oral

4.3

94.9

251

601

1104A

ICD-9 Finland

Dermatophytosis, Of foot

+∞

91.9

XQ845

NOMESCO Finland

Dermatoscopy

4.6

91.4

224

505

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.1

90.3

961

4911

S18

ICPC

Laceration/cut

1.7

89.8

3170

23500

J01FF01

ATC

clindamycin; systemic

1.8

89.7

1821

11570

L04AX03

ATC

methotrexate; systemic

2.3

88.8

723

3313

J02AC01

ATC

fluconazole; systemic

1.7

88.7

2221

14985

S97

ICPC

Chronic ulcer skin

2.6

86.2

545

2223

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

84.1

3198

24018

L30.0

ICD-10 Finland

Nummular dermatitis

3.1

83.1

360

1199

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

80.5

868

4446

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.1

80.2

360

1224

SPAT1301

SPAT

No procedures

1.7

78.7

2004

13481

SPAT1263

SPAT

Sampling

1.7

78.1

2609

18835

D01AC03

ATC

econazole; topical

2.6

77.6

482

1946

L04AX01

ATC

azathioprine; systemic

3.0

76.3

344

1172

C03CA01

ATC

furosemide; systemic

1.7

74.2

1961

13282

E000003, ,

ATC

3.0

73.4

346

1209

L30.8

ICD-10 Finland

Other specified dermatitis

3.5

73.1

257

752

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

4.1

71.3

200

500

D09AB01

ATC

zinc bandage without supplements; topical

4.1

71.0

198

493

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

70.9

410

1596

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

3.6

69.8

235

668

L04AA06

ATC

mycophenolic acid; systemic

4.2

69.3

190

467

L85.3

ICD-10 Finland

Xerosis cutis

5.3

69.0

140

269

XQ802

NOMESCO Finland

Epicutan test

3.1

68.6

302

1014

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.8

67.3

210

567

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

67.0

522

2335

E000002, ,

ATC

2.1

66.6

715

3641

XQ899

NOMESCO Finland

Other assessment of skin

10.4

65.9

L84

ICD-10 Finland

Corns and callosities

3.0

64.7

301

1043

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.0

64.6

740

3858

1101A

ICD-9 Finland

Dermatophytosis, Of nail

+∞

62.6

ZXC50

NOMESCO Finland

Cryotherapy

3.1

62.3

269

893

D07CC01

ATC

betamethasone and antibiotics; topical

1.9

60.7

819

4513

J01DA01

ATC

[U] cefalexin

1.5

60.5

3712

30215

E000006, ,

ATC

2.4

59.6

444

1945

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

58.4

917

5305

N02AX02

ATC

tramadol; systemic, rectal

1.5

57.7

2695

20593

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.0

57.6

656

3406

D07AA02

ATC

hydrocortisone; topical

1.9

57.5

866

4942

S29

ICPC

Skin symptom/complaint other

1.7

57.4

1334

8634

SPAT1260

SPAT

Consultation of another employee

1.8

57.3

1103

6779

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

56.7

1978

14151

L01BA01

ATC

methotrexate; systemic

2.9

56.6

272

959

127

Kela drug reimbursment

Transplant complication

4.3

56.2

148

353

SPAT1312

SPAT

General health counselling

1.6

55.6

1881

13349

S74

ICPC

Dermatophytosis

3.6

55.3

187

533

R60.0

ICD-10 Finland

Localized oedema

1.9

55.3

858

4939

11007

ICD-8 Finland

Dermatophytosis, Unguium

+∞

55.3

J01CE08

ATC

benzathine benzylpenicillin; parenteral

4.8

54.8

124

262

11004

ICD-8 Finland

Dermatophytosis, Inguinis

+∞

54.2

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

53.8

823

4713

B07.9

ICD-10 Finland

Verruca simplex

2.8

53.8

281

1037

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

4.4

53.1

133

305

SPAT1153

SPAT

Removal of sutures

1.6

52.5

1933

13944

-, ,

ICD-10 Finland

3.5

51.9

184

541

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

4.3

51.6

133

312

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

51.4

1791

12747

S22

ICPC

Nail symptom/complaint

2.2

51.2

487

2360

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.0

51.1

604

3171

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

50.6

646

3484

H02AB04

ATC

methylprednisolone; systemic

1.8

50.6

879

5228

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.0

49.5

579

3028

E000007, ,

ATC

2.4

49.2

345

1469

M79.6

ICD-10 Finland

Pain in limb

1.5

49.1

2647

20615

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

49.1

2296

17377

D01AC07

ATC

tioconazole; topical

2.7

48.6

269

1022

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

48.2

308

1256

N02BE01

ATC

paracetamol; systemic, rectal

1.8

48.2

5544

50539

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

48.2

1419

9691

UJF32

NOMESCO Finland

Coloscopy

1.6

48.0

1615

11375

P01BA02

ATC

hydroxychloroquine; oral

2.1

47.3

503

2540

L04AD01

ATC

ciclosporin; systemic

3.6

47.3

155

433

R06AE07

ATC

cetirizine; oral

1.5

47.0

2520

19552

L60.9

ICD-10 Finland

Nail disorder, unspecified

3.8

46.5

144

387

D05AX02

ATC

calcipotriol; topical

2.6

46.4

275

1081

L04AA01

ATC

[U] ciclosporin

4.3

46.1

120

284

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

46.0

1763

12754

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

3.2

46.0

184

584

L17

ICPC

Foot/toe symptom/complaint

1.5

45.8

1882

13816

R50.9

ICD-10 Finland

Fever, unspecified

1.7

45.0

971

6123

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.0

44.6

201

684

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

9.4

44.5

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.9

44.3

567

3054

SPAT1310

SPAT

Counselling related to known health issue

1.5

44.0

1838

13517

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.1

44.0

423

2055

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

3.9

43.7

131

344

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

3.2

43.5

171

537

Z94.0

ICD-10 Finland

Kidney transplant status

4.4

42.6

106

242

S21

ICPC

Skin texture symptom/complaint

1.7

42.1

973

6238

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

3.1

42.0

179

590

R06.0

ICD-10 Finland

Dyspnoea

1.5

41.6

1643

11916

L28.0

ICD-10 Finland

Lichen simplex chronicus

4.5

41.4

101

227

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

41.3

670

3891

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

41.0

427

2138

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

40.9

675

3940

R03AC02

ATC

salbutamol; inhalant

1.4

40.8

3180

26220

J01MA02

ATC

ciprofloxacin; systemic

1.4

40.5

2345

18312

QDH00

NOMESCO Finland

Avulsion of toe nail

8.7

40.5

G47.3

ICD-10 Finland

Sleep apnoea

1.5

39.7

1479

10578

TQW99

NOMESCO Finland

Other minor procedure on skin

2.2

39.6

343

1599

L20.0

ICD-10 Finland

Besnier prurigo

2.0

39.5

423

2139

S76

ICPC

Skin infection other

2.1

39.1

378

1840

J01CF05

ATC

flucloxacillin; systemic

2.0

38.5

475

2524

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

38.4

683

4069

ZY010

NOMESCO Finland

Hospital outpatient

2.2

38.4

320

1467

A07EC01

ATC

sulfasalazine; oral, rectal

1.9

38.3

486

2608

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

2.0

37.7

439

2287

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

37.5

968

6364

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

37.4

1108

7525

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.5

37.2

1678

12452

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.2

36.9

315

1459

M54.5

ICD-10 Finland

Low back pain

1.4

36.9

2127

16525

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

36.4

812

5143

SPAT1229

SPAT

Assessment of need for aid

1.9

36.1

466

2514

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.7

35.9

175

L40.5

ICD-10 Finland

Arthropathic psoriasis

3.3

35.4

135

416

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

35.3

768

4831

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

35.3

2422

19365

A02BC02

ATC

pantoprazole; systemic

1.4

35.1

4102

35848

A10AB05

ATC

insulin aspart; parenteral

1.9

35.1

497

2763

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

34.8

1316

9408

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

34.5

711

4408

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

34.4

396

2053

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

34.0

549

3176

L04AD02

ATC

tacrolimus; systemic

4.1

34.0

229

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

33.7

704

4379

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

33.5

2554

20726

QDB10, ,

SPAT

2.6

33.4

199

785

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

33.3

1113

7744

N03AX12

ATC

[U] gabapentin; oral

1.6

33.3

933

6241

L04AA13

ATC

[U] leflunomide

2.8

33.2

163

582

D02AX

ATC

Other emollients and protectives

2.6

33.2

196

770

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

33.1

2367

18994

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.5

32.9

1044

7180

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.7

32.8

174

647

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.0

32.8

141

X58

ICD-10 Finland

Exposure to other specified factors

1.6

32.8

893

5932

B35.5

ICD-10 Finland

Tinea imbricata

117.3

32.7

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.8

32.6

549

3216

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

32.3

1103

7701

D06AX01

ATC

fusidic acid; topical

1.8

32.2

528

3067

J01AA02

ATC

doxycycline; systemic

1.4

32.1

4586

41104

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

32.1

1544

11545

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

31.9

2046

16097

S06

ICPC

Rash localized

2.0

31.8

349

1778

XQ800

NOMESCO Finland

Prick test

1.9

31.7

401

2146

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

31.7

392

2082

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.5

31.6

111

325

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.9

31.5

429

2352

N03AX16

ATC

[U] pregabalin

1.5

31.2

1310

9533

M48.0

ICD-10 Finland

Spinal stenosis

1.6

31.1

737

4728

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

4.8

31.0

148

D06BB10

ATC

imiquimod; topical

2.0

31.0

331

1671

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

30.7

2371

19204

SPAT1254

SPAT

Administration of medicine

1.6

30.6

838

5567

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.5

30.6

194

789

A10AC01

ATC

insulin (human); parenteral

1.8

30.4

449

2525

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.1

30.4

126

409

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

2.7

30.3

159

588

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

30.3

1588

12039

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

30.0

1050

7358

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

29.8

1260

9174

J01FA06

ATC

roxithromycin; oral

1.4

29.4

2174

17449

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.2

29.4

255

1189

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

29.2

2156

17299

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.8

29.0

431

2428

J01CA04

ATC

amoxicillin; systemic

1.4

28.9

4836

44019

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

28.9

428

2410

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.5

28.7

188

776

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

103.9

28.7

M04AA01

ATC

allopurinol; systemic

1.6

28.5

816

5469

J01DA09

ATC

[U] cefadroxil

1.4

28.4

1436

10795

B37.2

ICD-10 Finland

Candidiasis of skin and nail

4.5

28.2

152

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

28.1

1833

14391

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.5

28.0

180

737

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

28.0

203

878

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

27.9

235

1083

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

27.8

363

1963

M07.3

ICD-10 Finland

Other psoriatic arthropathies

3.8

27.8

227

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

27.7

1070

7639

ZXC15

NOMESCO Finland

Use of photodynamic technique

3.2

27.6

107

334

L73.8

ICD-10 Finland

Other specified follicular disorders

3.6

27.4

248

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

27.4

205

899

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

27.3

1789

14047

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

27.0

347

1866

WXQ12

NOMESCO Finland

Psoralen - Ultraviolet A therapy with local sensitivisation

6.4

26.9

L04AB04

ATC

adalimumab; parenteral

2.7

26.8

149

568

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.6

26.6

154

599

L60.0

ICD-10 Finland

Ingrowing nail

2.0

26.4

296

1520

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

3.0

26.3

117

396

L29.9

ICD-10 Finland

Pruritus, unspecified

2.4

26.1

180

761

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

26.1

2515

20914

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

26.1

555

3460

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

26.0

531

3273

RJ411, ,

NOMESCO Finland

5.0

26.0

110

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

26.0

1298

9716

AA1AD

NOMESCO Finland

CT of head and brain

1.4

25.8

1691

13251

B01AB05

ATC

enoxaparin; parenteral

1.4

25.7

1763

13912

SPAT1325

SPAT

Vaccination

1.4

25.7

1827

14503

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.5

25.6

164

670

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

25.5

1634

12752

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

7.4

25.0

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.2

25.0

218

1019

L28.1

ICD-10 Finland

Prurigo nodularis

4.0

24.9

172

J46

ICD-10 Finland

Status asthmaticus

2.4

24.9

174

741

L43.9

ICD-10 Finland

Lichen planus, unspecified

2.7

24.8

130

482

E66.01

ICD-10 Finland

Obesity due to excess calories

1.7

24.7

501

3082

J01MA12

ATC

levofloxacin; systemic

1.5

24.7

1050

7623

SPAT1216

SPAT

Assessment of functional ability

1.5

24.6

848

5905

A10AB01

ATC

insulin (human); parenteral

2.2

24.6

204

934

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

24.5

474

2879

A02BC03

ATC

lansoprazole; oral

1.4

24.4

1546

12029

J01FA10

ATC

azithromycin; systemic

1.3

24.4

3117

26881

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

24.3

721

4862

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

24.2

426

2523

R06AX27

ATC

desloratadine; oral

1.4

24.0

1488

11536

M25.5

ICD-10 Finland

Pain in joint

1.3

23.9

1818

14546

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

2.2

23.9

204

945

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

4.3

23.8

143

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.6

23.8

133

509

A02BC05

ATC

esomeprazole; systemic

1.3

23.8

2250

18587

M10.9

ICD-10 Finland

Gout, unspecified

1.7

23.7

451

2727

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

23.7

1059

7753

NHQ40

NOMESCO Finland

Amputation of toe

2.8

23.7

115

409

A07AA02

ATC

nystatin; oral

1.9

23.7

308

1663

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.7

23.7

127

476

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.5

23.6

150

611

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

23.6

1267

9585

ZX120

NOMESCO Finland

Intravenous

1.6

23.5

529

3344

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

23.4

1009

7336

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

23.3

1060

7782

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.9

23.3

306

1657

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

23.3

4132

37160

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

23.3

616

4047

A10AE05

ATC

insulin detemir; parenteral

1.9

23.2

315

1724

E66.8

ICD-10 Finland

Other obesity

1.9

23.2

298

1603

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

1.9

23.1

289

1542

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

23.0

318

1751

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.1

23.0

220

1066

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.3

22.9

183

826

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.7

22.8

399

2357

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.5

22.8

149

615

SPAT1262

SPAT

Handing over of treatment supplies

1.4

22.8

991

7214

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

22.8

332

1859

S01

ICPC

Pain/tenderness of skin

1.9

22.7

281

1492

SPAT1255

SPAT

Intravenous administration of medicine

1.7

22.6

396

2342

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

22.6

392

2312

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

22.5

769

5341

L30.1

ICD-10 Finland

Dyshidrosis [pompholyx]

5.0

22.5

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.1

22.5

209

1002

K02.1

ICD-10 Finland

Caries of dentine

1.3

22.5

3342

29278

L95.8

ICD-10 Finland

Other vasculitis limited to skin

7.0

22.4

SFA10

NOMESCO Finland

One-surface restoration

1.3

22.4

3104

26938

WZC00, ,

SPAT

1.5

22.4

834

5894

C07AB07

ATC

bisoprolol; oral

1.3

22.3

2802

23998

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

22.2

346

1977

B01AA03

ATC

warfarin; systemic

1.4

22.2

1059

7838

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

22.1

2133

17621

L04AC13

ATC

ixekizumab; parenteral

6.6

22.1

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

21.9

2945

25423

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.5

21.8

810

5719

Z00.0

ICD-10 Finland

General medical examination

1.4

21.7

1070

7960

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

21.7

3614

32065

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

21.6

628

4210

E000004, ,

ATC

2.7

21.6

120

458

H13

ICPC

Plugged feeling ear

1.4

21.6

1127

8467

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

21.6

722

4988

A10AE06

ATC

insulin degludec; parenteral

2.1

21.6

214

1052

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

21.4

2552

21664

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

3.4

21.4

225

J05AB11

ATC

valaciclovir; oral

1.5

21.4

770

5401

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.6

21.4

124

484

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

21.4

781

5495

L40.8

ICD-10 Finland

Other psoriasis

3.8

21.3

169

R42

ICD-10 Finland

Dizziness and giddiness

1.4

21.3

1257

9636

R03BA08

ATC

ciclesonide; inhalant

1.6

21.3

459

2868

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

21.2

425

2606

R53

ICD-10 Finland

Malaise and fatigue

1.4

21.2

1359

10560

H02AB07

ATC

prednisone; oral

1.5

21.2

707

4884

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

21.1

1408

11008

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

21.1

2637

22516

M01CB01

ATC

sodium aurothiomalate; parenteral

3.1

21.0

273

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

20.9

1703

13710

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

20.9

430

2653

L28

ICPC

Limited function/disability (L)

1.4

20.8

1060

7927

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

2.8

20.8

107

393

L43.8

ICD-10 Finland

Other lichen planus

2.7

20.6

113

429

D05AX03

ATC

calcitriol; topical

3.0

20.6

313

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

20.5

3756

33615

T89

ICPC

Diabetes insulin dependent

2.0

20.4

233

1204

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

20.3

399

2434

A02BC01

ATC

omeprazole; systemic

1.3

20.2

1456

11502

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

3.1

20.2

274

N02BF01

ATC

gabapentin; oral

1.5

20.2

580

3877

P01AB01

ATC

metronidazole; oral, rectal

1.3

20.2

2069

17182

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

20.1

406

2495

N05BB01

ATC

hydroxyzine; systemic

1.8

20.1

319

1834

A10AE04

ATC

insulin glargine; parenteral

1.6

20.0

561

3729

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

20.0

249

1326

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.3

19.9

145

629

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

19.8

1437

11361

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.7

19.8

382

2318

11009

ICD-8 Finland

Dermatophytosis, Unspecified

+∞

19.8

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

19.8

4142

37608

RJ420, ,

NOMESCO Finland

5.0

19.7

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

5.0

19.7

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

19.7

954

7069

L88

ICPC

Rheumatoid/seropositive arthritis

2.0

19.6

226

1172

L60.3

ICD-10 Finland

Nail dystrophy

4.6

19.6

101

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.1

19.5

191

934

QXB99, ,

SPAT

2.2

19.5

174

821

L04AB01

ATC

etanercept; parenteral

2.8

19.5

350

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

3.4

19.5

199

TK800

NOMESCO Finland

Hemodialysis

2.3

19.5

140

604

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.1

19.5

187

908

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

19.4

800

5756

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.4

19.3

133

564

RJ421, ,

NOMESCO Finland

5.1

19.3

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.6

19.3

446

2836

L23.0

ICD-10 Finland

Allergic contact dermatitis due to metals

3.6

19.2

177

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

4.2

19.2

119

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

19.2

200

1002

J01AA07

ATC

tetracycline; systemic

1.5

19.0

718

5077

NH3BG

NOMESCO Finland

MRI of foot

4.0

19.0

133

PD4CC

NOMESCO Finland

Very extensive arterigography of lower extremity with X-ray

4.0

19.0

133

R02

ICPC

Shortness of breath/dyspnoea

1.5

19.0

742

5282

137

Kela drug reimbursment

Uraemia requiring dialysis

3.4

19.0

198

A12AA04

ATC

calcium carbonate; oral

2.7

18.9

102

384

L08.0

ICD-10 Finland

Pyoderma

3.3

18.9

218

WZC30

NOMESCO Finland

Teaching

1.4

18.9

944

7025

H02AB09

ATC

hydrocortisone; systemic

2.3

18.9

141

619

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

3.7

18.8

161

L12.0

ICD-10 Finland

Bullous pemphigoid

4.2

18.8

121

N02AA05

ATC

oxycodone; systemic

1.4

18.8

1018

7681

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

4.0

18.7

130

SBA00

NOMESCO Finland

Microbiological examinations

2.3

18.7

140

615

L04AB06

ATC

golimumab; parenteral

3.7

18.7

157

M05BA04

ATC

alendronic acid; oral

1.6

18.7

418

2636

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.4

18.6

130

554

Z94.1

ICD-10 Finland

Heart transplant status

7.0

18.6

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

18.6

1411

11213

Z00.8

ICD-10 Finland

Other general examinations

1.6

18.6

436

2780

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

18.5

1429

11388

R03DC03

ATC

montelukast; oral

1.4

18.4

832

6082

R03BA01

ATC

beclometasone; inhalant

1.5

18.4

714

5075

N77.1*B37.3

ICD-10 Finland

Candidiasis of vulva and vagina

3.0

18.4

279

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

18.3

963

7226

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

18.3

1051

8002

H04AA01

ATC

glucagon; nasal, parenteral

2.4

18.3

124

522

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.0

18.2

265

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

18.2

1424

11366

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

18.1

374

2310

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

18.1

370

2279

C03DA01

ATC

spironolactone; oral

1.5

18.1

677

4779

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

18.0

3800

34315

N05AH04

ATC

quetiapine; oral

1.4

18.0

911

6793

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.5

18.0

171

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.8

17.9

277

1579

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

17.9

510

3401

WW200

NOMESCO Finland

Immunization

2.1

17.9

159

750

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.0

17.9

197

1007

B37.08

ICD-10 Finland

Other candidal stomatitis

4.2

17.8

109

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

17.7

985

7456

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

4.5

17.7

Z08

ICPC

Social welfare problem

2.8

17.7

307

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

17.7

358

2201

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

17.6

1375

10958

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

17.6

670

4741

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.8

17.6

330

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

4.0

17.6

123

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

3.9

17.6

132

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

4.6

17.5

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

17.4

790

5775

L50.9

ICD-10 Finland

Urticaria, unspecified

2.0

17.4

197

1016

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

17.4

630

4418

N06AX21

ATC

duloxetine; oral

1.5

17.3

607

4230

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.0

17.3

176

875

N06AX11

ATC

mirtazapine; oral

1.3

17.2

1820

15105

SPAT1104

SPAT

Monitoring of emergency patient

1.7

17.1

345

2119

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.1

17.0

168

825

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

17.0

300

1776

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

17.0

681

4869

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

16.9

1162

9086

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

16.9

386

2447

D11AH01

ATC

tacrolimus; topical

3.4

16.8

179

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.3

16.8

124

543

B36.0

ICD-10 Finland

Pityriasis versicolor

3.0

16.7

251

S08

ICPC

Skin colour change

1.7

16.7

306

1831

A01AB09

ATC

miconazole; local oral

1.6

16.7

408

2627

JN4AD

NOMESCO Finland

Body CT examination

1.4

16.6

657

4682

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

16.6

448

2952

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

3.5

16.6

161

L93.0

ICD-10 Finland

Discoid lupus erythematosus

4.4

16.6

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

16.6

568

3938

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

16.6

1173

9210

A10AA01, ,

ATC

2.2

16.5

138

636

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

16.5

434

2843

SPAT1101

SPAT

Orthostatic test

1.8

16.5

230

1272

I50.0

ICD-10 Finland

Congestive heart failure

1.6

16.4

394

2526

J04BA02

ATC

dapsone; oral

4.0

16.4

112

SPAT1211

SPAT

Application of soft bandage

1.5

16.3

455

3019

L30.2

ICD-10 Finland

Cutaneous autosensitization

40.2

16.3

A10AB04

ATC

insulin lispro; parenteral

2.0

16.3

165

819

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.1

16.3

144

679

SPAT1097

SPAT

Recording of ECG

1.4

16.2

761

5595

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

16.2

3049

27025

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

16.1

517

3535

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

16.1

326

2004

L21.0

ICD-10 Finland

Seborrhoea capitis

2.9

16.1

246

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.2

16.1

189

R06AX13

ATC

loratadine; oral

1.4

16.1

706

5130

A41.9

ICD-10 Finland

Sepsis, unspecified

1.9

16.0

199

1061

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

16.0

225

1248

C08CA01

ATC

amlodipine; oral

1.3

15.9

2175

18580

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

15.9

1510

12336

M01AH01

ATC

celecoxib; oral

1.4

15.9

903

6851

L99

ICPC

Musculoskeletal disease other

2.2

15.9

129

588

R01AD12

ATC

fluticasone furoate; nasal

1.3

15.8

1581

13000

R03BB04

ATC

tiotropium bromide; inhalant

1.5

15.8

539

3732

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

15.7

704

5130

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.4

15.7

106

446

J01AA04

ATC

lymecycline; systemic

1.4

15.7

626

4468

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.9

15.7

207

1125

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

15.7

717

5247

SPAT1285

SPAT

Provision of consultation response

1.7

15.5

271

1601

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

15.5

1880

15826

ZXD05

NOMESCO Finland

Urgent procedure

1.3

15.5

1567

12900

L60.8

ICD-10 Finland

Other nail disorders

2.9

15.5

257

C08CA13

ATC

lercanidipine; oral

1.4

15.4

773

5743

R35

ICD-10 Finland

Polyuria

1.6

15.4

399

2604

A06AD11

ATC

lactulose; oral

1.4

15.4

769

5712

SPAT1210

SPAT

Application of cast or individual aid

1.9

15.4

208

1140

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

15.3

350

2217

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

15.3

286

1722

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

15.3

525

3640

UKC02

NOMESCO Finland

Cystoscopy

1.4

15.2

905

6913

J05AB01

ATC

aciclovir; systemic

1.3

15.2

1095

8608

R01AD09

ATC

mometasone; nasal

1.2

15.2

2363

20458

A11CC03

ATC

alfacalcidol; systemic

2.1

15.1

140

672

R03BA05

ATC

fluticasone; inhalant

1.4

15.1

897

6849

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

15.1

348

2210

M03BX02

ATC

tizanidine; oral

1.2

15.1

3399

30619

SPAT1058

SPAT

PEF monitoring instruction

1.6

15.1

401

2634

N06AA09

ATC

amitriptyline; systemic

1.5

15.0

469

3188

A02BA02

ATC

ranitidine; systemic

1.3

15.0

969

7493

SPAT1252

SPAT

Overall medication plan or its review

1.6

15.0

346

2197

SPAT1053

SPAT

Memory test

1.4

15.0

721

5320

A98

ICPC

Health maint/preventive medicine

1.5

15.0

5947

57529

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.5

14.9

143

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

14.9

240

1386

6929X

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[DERMATITITIS ARTEFACTA NUD]

6.5

14.9

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.3

14.9

115

514

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

14.8

627

4521

M01AH05

ATC

etoricoxib; oral

1.2

14.8

3460

31258

A01

ICPC

Pain general/multiple sites

1.5

14.7

530

3708

L71.8

ICD-10 Finland

Other rosacea

2.4

14.7

392

ZZA00

NOMESCO Finland

Split skin graft

2.0

14.7

158

802

S75

ICPC

Moniliasis/candidiasis skin

3.5

14.7

140

R05

ICD-10 Finland

Cough

1.3

14.6

1138

9038

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.9

14.6

227

M79.1

ICD-10 Finland

Myalgia

1.4

14.6

755

5639

L43.0

ICD-10 Finland

Hypertrophic lichen planus

3.8

14.5

113

J01FA09

ATC

clarithromycin; systemic

1.3

14.5

1576

13070

-1, ,

NOMESCO Finland

1.3

14.5

1696

14191

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

2.8

14.5

250

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

14.5

1102

8727

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.2

14.4

125

585

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

14.4

711

5266

QBA10

NOMESCO Finland

Incision of skin of trunk

2.8

14.4

262

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.5

14.3

337

K07.60

ICD-10 Finland

Snapping jaw

1.8

14.3

233

1350

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.6

14.3

310

1939

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

2.3

14.3

109

484

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.9

14.3

219

J45

ICD-10 Finland

Asthma

1.5

14.3

515

3604

SPAT1240

SPAT

Therapeutic discussion

1.5

14.3

471

3240

WX892

NOMESCO Finland

Monitored bed care

1.5

14.2

410

2740

T82

ICPC

Obesity

1.8

14.2

202

1124

K07

ICPC

Swollen ankles/oedema

1.7

14.2

254

1511

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

14.2

1407

11532

L73.9

ICD-10 Finland

Follicular disorder, unspecified

3.9

14.2

106

R05

ICPC

Cough

1.3

14.1

1297

10527

A10AA02, ,

ATC

1.9

14.1

166

870

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

14.0

425

2871

ND1AE

NOMESCO Finland

Wrist ultrasound examination

4.7

14.0

E66.00

ICD-10 Finland

Metabolic syndrome

1.6

13.9

301

1882

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

13.9

607

4401

G04BD12

ATC

mirabegron; oral

1.4

13.9

641

4693

C08CA02

ATC

felodipine; oral

1.5

13.9

490

3416

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

2.1

13.9

137

675

L71.9

ICD-10 Finland

Rosacea, unspecified

2.1

13.9

137

675

9751

FHL

Nail removal in the operating room or under anesthesia

17.6

13.8

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

13.8

282

1740

J01MA14

ATC

moxifloxacin; systemic

1.5

13.7

460

3173

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

13.7

588

4250

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

13.7

968

7578

R06AE09

ATC

levocetirizine; oral

1.4

13.7

680

5041

Z3231

NOMESCO Finland

Registered nurse

1.3

13.7

1444

11921

R01AD08

ATC

fluticasone; nasal

1.3

13.6

1435

11841

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

13.6

171

916

QDH05

NOMESCO Finland

Correction of deformity of toe nail

4.9

13.5

L50.3

ICD-10 Finland

Dermatographic urticaria

2.4

13.5

377

A41.8

ICD-10 Finland

Other specified sepsis

2.2

13.5

111

509

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

13.5

498

3500

N05CD07

ATC

temazepam; oral

1.4

13.5

558

4006

OAB42, ,

SPAT

1.4

13.5

685

5096

R96

ICPC

Asthma

1.5

13.5

499

3509

SFA20

NOMESCO Finland

Two-surface restoration

1.2

13.5

3214

28972

KMAK, ,

NOMESCO Finland

1.2

13.4

2680

23731

C07AB02

ATC

metoprolol; systemic

1.3

13.4

1006

7944

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.7

13.4

261

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

13.4

544

3895

Z01.2

ICD-10 Finland

Dental examination

1.2

13.3

2468

21675

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

13.3

291

1824

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.7

13.3

263

1607

R51.80

ICD-10 Finland

Headache

1.4

13.3

760

5761

L03

ICPC

Low back symptom/complaint

1.3

13.3

1522

12679

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

13.3

384

2568

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.2

13.3

110

506

M01AH02

ATC

rofecoxib; oral

1.4

13.3

618

4530

B05DA

ATC

Isotonic solutions

3.1

13.3

170

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

13.2

388

2604

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.6

13.2

328

2121

L14

ICPC

Leg/thigh symptom/complaint

1.5

13.1

422

2886

S15

ICPC

Foreign body in skin

1.6

13.1

347

2278

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.7

13.0

242

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

13.0

183

1016

C10AC01

ATC

colestyramine; oral

2.0

13.0

139

705

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.7

13.0

212

1231

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.2

13.0

157

J20

ICD-10 Finland

Acute bronchitis

1.4

12.9

513

3656

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.8

12.8

188

1057

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.5

12.8

356

2361

L23.1

ICD-10 Finland

Allergic contact dermatitis due to adhesives

4.7

12.8

R07.3

ICD-10 Finland

Other chest pain

1.4

12.8

539

3883

D06BX01

ATC

metronidazole; topical

1.4

12.7

499

3547

W19

ICD-10 Finland

Unspecified fall

1.4

12.7

514

3674

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.5

12.7

367

2454

N30.0

ICD-10 Finland

Acute cystitis

1.3

12.7

785

6023

M81.4

ICD-10 Finland

Drug-induced osteoporosis

3.9

12.7

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.8

12.7

204

1180

D07XB05

ATC

dexamethasone; topical

2.0

12.7

126

623

R11

ICD-10 Finland

Nausea and vomiting

1.5

12.6

427

2950

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.8

12.5

202

1169

1103A

ICD-9 Finland

Dermatophytosis, Of groin and perianal area

+∞

12.5

ZY010, ,

SPAT

2.4

12.5

360

SPAT1234

SPAT

Support of social functional capacity

1.6

12.5

259

1604

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.5

12.5

415

2859

EB1VA, ,

NOMESCO Finland

1.3

12.5

929

7322

Z71.8

ICD-10 Finland

Other specified counselling

1.2

12.4

1789

15274

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

12.4

616

4563

L50.8

ICD-10 Finland

Other urticaria

2.3

12.4

411

S20

ICPC

Corn/callosity

2.1

12.4

121

594

D07AB01

ATC

clobetasone; topical

1.9

12.4

148

781

205

Kela drug reimbursment

Chronic hypertension

1.3

12.3

1396

11601

F61.0

ICD-10 Finland

Mixed personality disorders

2.4

12.3

344

M66.0

ICD-10 Finland

Rupture of popliteal cyst

2.4

12.3

326

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

12.3

238

1448

C05AA08

ATC

fluocortolone; rectal, topical

1.4

12.3

678

5111

Z2446

NOMESCO Finland

Social worker

1.6

12.3

312

2029

L40

ICD-10 Finland

Psoriasis

2.1

12.3

110

523

A07EA06

ATC

budesonide; oral, local oral

1.8

12.2

184

1044

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

12.2

486

3465

G44.2

ICD-10 Finland

Tension-type headache

1.4

12.2

637

4759

SFA00

NOMESCO Finland

Small restoration

1.4

12.2

718

5467

ZX108

NOMESCO Finland

Inhalation

3.1

12.2

158

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

2.5

12.1

304

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.5

12.1

354

2375

B37.8

ICD-10 Finland

Candidiasis of other sites

12.4

12.1

L01.1

ICD-10 Finland

Impetiginization of other dermatoses

3.5

12.1

114

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

1.9

12.1

143

752

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

12.0

308

2006

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

12.0

319

2095

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.6

12.0

298

1928

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

12.0

1327

10996

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

12.0

325

2146

D07CB01

ATC

triamcinolone and antibiotics; topical

2.2

11.9

100

463

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

11.9

410

2843

L23.9

ICD-10 Finland

Allergic contact dermatitis, unspecified cause

2.9

11.9

192

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.4

11.9

510

3684

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.4

11.9

325

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

11.9

894

7054

G04BD08

ATC

solifenacin; oral

1.5

11.8

322

2126

M01AC06

ATC

meloxicam; systemic, rectal

1.2

11.8

1838

15804

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.9

11.8

149

800

J01XC01

ATC

fusidic acid; systemic

2.5

11.8

290

L01BC02

ATC

fluorouracil; systemic, topical

3.1

11.8

161

R52.9

ICD-10 Finland

Pain, unspecified

1.4

11.8

519

3768

F05.9

ICD-10 Finland

Delirium, unspecified

2.0

11.8

120

599

NGQ20

NOMESCO Finland

Amputation of lower leg

3.5

11.8

116

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.2

11.8

100

466

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.9

11.7

139

731

QXA70, ,

SPAT

2.3

11.7

358

M07.0*L40.5

ICD-10 Finland

Distal interphalangeal psoriatic arthropathy

5.1

11.7

A04

ICPC

Weakness/tiredness general

1.3

11.7

784

6085

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

11.7

301

1964

A28

ICPC

Limited function/disability NOS

1.3

11.6

926

7358

B03XA02

ATC

darbepoetin alfa; parenteral

2.0

11.6

118

588

L04AA17

ATC

[U] adalimumab

4.7

11.6

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

11.6

1323

10991

C10AX09

ATC

ezetimibe; oral

1.3

11.6

942

7504

C09CA01

ATC

losartan; oral

1.3

11.6

1377

11495

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

11.6

682

5191

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.0

11.6

125

637

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.7

11.6

223

S99

ICPC

Skin disease other

2.0

11.6

121

610

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

11.6

564

4167

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

2.9

11.5

190

B01AC04

ATC

clopidogrel; oral

1.3

11.5

894

7081

H03AA01

ATC

levothyroxine sodium; systemic

1.3

11.5

1067

8651

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.5

11.5

347

2345

RJ424, ,

NOMESCO Finland

+∞

11.5

K08.3

ICD-10 Finland

Retained dental root

1.5

11.4

422

2966

L73.2

ICD-10 Finland

Hidradenitis suppurativa

2.8

11.4

202

S19

ICPC

Skin injury other

1.7

11.4

207

1238

L13

ICPC

Hip symptom/complaint

1.3

11.4

968

7757

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

11.4

329

2201

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

1.9

11.4

136

718

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

11.4

342

2308

R03BA02

ATC

budesonide; inhalant

1.3

11.4

861

6797

EBA00

NOMESCO Finland

Extraction of tooth

1.2

11.3

1945

16879

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.6

11.3

235

1456

XG466

NOMESCO Finland

Sleep oxymetry

1.8

11.3

162

906

L95.9

ICD-10 Finland

Vasculitis limited to skin, unspecified

3.6

11.3

100

XKD00

NOMESCO Finland

Uroflowmetry

1.3

11.3

911

7251

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

11.3

724

5582

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.7

11.3

199

1182

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

3.0

11.3

155

D07AC14

ATC

methylprednisolone aceponate; topical

1.7

11.2

214

1297

WX290

NOMESCO Finland

Other blockage of nerve

1.2

11.2

2493

22176

69619

ICD-8 Finland

Psoriasis and similar disorders, Psoriasis alia sive NUD (vulgaris)

4.3

11.2

S09

ICPC

Infected finger/toe

1.8

11.2

168

953

SFA30

NOMESCO Finland

Three-surface restoration

1.2

11.1

2279

20111

J02AB02

ATC

ketoconazole; oral

1.9

11.1

131

688

TNH31

NOMESCO Finland

Prefabricated orthosis, ankle or foot

2.7

11.1

222

ZXA00

NOMESCO Finland

Right side

1.3

11.1

1329

11095

N06AB04

ATC

citalopram; systemic

1.3

11.1

988

7961

H01

ICPC

Ear pain/earache

1.4

11.1

559

4151

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

11.0

212

1288

Z94.2

ICD-10 Finland

Lung transplant status

8.0

11.0

QDH01

NOMESCO Finland

Excision of nail bed in toe

5.3

11.0

B86

ICD-10 Finland

Scabies

1.9

11.0

127

662

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

11.0

219

1342

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.7

11.0

216

1319

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.7

11.0

205

1235

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

11.0

1287

10718

B37.4

ICD-10 Finland

Candidiasis of other urogenital sites

8.5

11.0

L24.9

ICD-10 Finland

Irritant contact dermatitis, unspecified cause

3.8

11.0

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

11.0

189

1115

K59.1

ICD-10 Finland

Functional diarrhoea

1.6

11.0

273

1768

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.8

11.0

151

835

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

2.1

10.9

460

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.4

10.9

289

NH3CG

NOMESCO Finland

Extensive MRI of foot

3.2

10.9

137

ZXE10

NOMESCO Finland

More than one and less than three hours

1.2

10.9

1835

15878

G04CA02

ATC

tamsulosin; oral

1.2

10.9

1415

11918

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.4

10.9

314

S70.0

ICD-10 Finland

Contusion of hip

1.7

10.9

199

1194

S02

ICPC

Pruritus

1.7

10.9

176

1021

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

10.9

1879

16306

QXA20

NOMESCO Finland

Skin abrasion, unspecified location

4.1

10.8

R4180, ,

SPAT

2.3

10.8

327

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

10.8

1042

8480

SPAT1043

SPAT

Audiometry

1.4

10.8

506

3713

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.0

10.8

107

530

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.3

10.7

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.7

10.7

192

1145

QCA99

NOMESCO Finland

Other local destruction of skin of upper limb

4.4

10.7

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

10.7

1239

10306

N06AA12

ATC

doxepin; systemic

1.6

10.7

237

1495

A03

ICPC

Fever

1.3

10.6

827

6548

L60.1

ICD-10 Finland

Onycholysis

2.6

10.6

222

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.9

10.6

138

750

N05CF01

ATC

zopiclone; oral

1.2

10.5

1632

13998

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

10.5

929

7478

A10BJ06

ATC

semaglutide; parenteral

1.5

10.5

276

1810

H26.02

ICD-10 Finland

Presenil cataract

1.9

10.5

135

731

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

2.0

10.4

108

543

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

10.4

615

4681

TGC00

NOMESCO Finland

Bronchial lavation

1.9

10.4

130

697

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

10.4

187

1117

R06AX22

ATC

ebastine; oral

1.3

10.4

785

6189

R01AD11

ATC

triamcinolone; nasal

1.4

10.4

395

2793

L03.8

ICD-10 Finland

Cellulitis of other sites

3.2

10.4

121

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.3

10.3

627

4792

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

2.8

10.3

174

A08

ICPC

Swelling

1.5

10.3

286

1897

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

10.3

480

3518

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.4

10.3

442

3194

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.7

10.3

208

R06.5

ICD-10 Finland

Mouth breathing

1.4

10.3

473

3459

S87

ICPC

Dermatitis/atopic eczema

1.9

10.3

119

622

A05

ICPC

Feeling ill

1.6

10.3

268

1754

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

3.1

10.3

132

WX213

NOMESCO Finland

Lower leg blockade

2.6

10.3

220

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.9

10.3

125

665

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.6

10.3

231

1462

6961A

ICD-9 Finland

Psoriasis and similar disorders, Other psoriasis[PSORIASIS VULGARIS]

4.9

10.2

RJ422, ,

NOMESCO Finland

9.6

10.2

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.8

10.2

149

839

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

10.2

377

2652

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

3.6

10.2

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

10.2

433

3125

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.9

10.2

132

717

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

10.2

388

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.1

10.1

421

M01AX17

ATC

nimesulide; oral

1.2

10.1

1171

9729

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

10.1

279

1849

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

2.6

10.1

216

S91

ICPC

Psoriasis

2.6

10.1

216

L29.8

ICD-10 Finland

Other pruritus

2.3

10.1

325

ZXA10

NOMESCO Finland

Bilateral

1.3

10.1

894

7196

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

2.8

10.1

171

J01FA01

ATC

erythromycin; systemic

1.3

10.1

604

4608

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

10.1

236

1508

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

10.1

680

5279

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.5

10.0

288

1926

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.6

10.0

235

1502

S17

ICPC

Abrasion/scratch/blister

1.9

10.0

116

607

6929B

ICD-9 Finland

Contact dermatitis and other eczema, Unspecified cause[ECZEMA INFECTIOSUM]

4.6

10.0

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

4.6

10.0

M16.7

ICD-10 Finland

Other secondary coxarthrosis

2.9

10.0

161

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.8

10.0

139

772

R03AK08

ATC

formoterol and beclometasone; inhalant

1.6

10.0

211

1316

S06.0

ICD-10 Finland

Concussion

1.4

9.9

531

3980

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

2.6

9.9

212

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.6

9.9

247

1600

UJH02

NOMESCO Finland

Anoscopy

1.7

9.9

191

1162

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

2.8

9.9

167

A29

ICPC

General symptom/complaint other

1.3

9.9

689

5370

J01EA01

ATC

trimethoprim; systemic

1.2

9.9

1141

9475

V03AE01

ATC

polystyrene sulfonate; oral

2.3

9.9

328

C10AA05

ATC

atorvastatin; oral

1.2

9.9

2353

20994

T90

ICPC

Diabetes non-insulin dependent

1.2

9.9

1328

11216

C09AA02

ATC

enalapril; systemic

1.3

9.8

974

7946

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

1.8

9.8

132

725

H3603, E113,

ICD-10 Finland

2.7

9.8

196

QDB99, ,

SPAT

5.1

9.8

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

9.8

405

2907

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

9.8

241

1558

K59.0

ICD-10 Finland

Constipation

1.5

9.8

267

1767

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

4.5

9.8

L91.0

ICD-10 Finland

Hypertrophic scar

2.4

9.7

274

A10BJ02

ATC

liraglutide; parenteral

1.8

9.7

145

822

B99

ICPC

Blood/lymph/spleen disease other

3.5

9.7

H26.3

ICD-10 Finland

Drug-induced cataract

3.2

9.7

116

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.7

9.7

159

927

207

Kela drug reimbursment

Chronic arrhythmias

1.3

9.7

825

6606

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

9.7

402

2889

H26.4

ICD-10 Finland

After-cataract

1.4

9.7

478

3539

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

9.7

380

2705

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.6

9.6

218

1382

L04AC18

ATC

risankizumab; parenteral

5.3

9.6

N03AG01

ATC

valproic acid; systemic, rectal

1.5

9.6

275

1838

D69.2

ICD-10 Finland

Other nonthrombocytopenic purpura

4.2

9.6

M10.3

ICD-10 Finland

Gout due to impairment of renal function

3.5

9.6

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

3.1

9.6

122

S22.3

ICD-10 Finland

Fracture of rib

1.4

9.6

379

2701

H3600, E103,

ICD-10 Finland

2.5

9.6

234

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

1.7

9.6

167

991

ZXA05

NOMESCO Finland

Left side

1.2

9.5

1209

10140

S91.3

ICD-10 Finland

Open wound of other parts of foot

1.8

9.5

132

732

R01AD01

ATC

beclometasone; nasal

1.3

9.5

719

5666

RJ210, ,

NOMESCO Finland

4.8

9.5

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.2

9.5

353

I50

ICD-10 Finland

Heart failure

1.8

9.5

144

821

N05AF03

ATC

chlorprothixene; systemic

1.9

9.5

121

654

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.8

9.5

148

851

B36.8

ICD-10 Finland

Other specified superficial mycoses

3.5

9.5

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.2

9.5

328

D06BX02

ATC

ingenol mebutate; topical

2.3

9.5

284

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

9.5

484

3603

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.8

9.5

149

859

S10

ICPC

Boil/carbuncle

1.5

9.5

300

2049

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

9.4

510

3830

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

9.4

145

830

L16

ICPC

Ankle symptom/complaint

1.3

9.4

588

4512

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.8

9.4

129

713

N03AX09

ATC

lamotrigine; oral

1.6

9.4

208

1311

M01AX05

ATC

glucosamine; oral

1.3

9.4

903

7336

WZC30, ,

SPAT

1.4

9.4

428

3125

L81.7

ICD-10 Finland

Pigmented purpuric dermatosis

3.7

9.4

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

1.9

9.4

110

578

U07

ICPC

Urine symptom/complaint other

1.4

9.4

419

3049

H3601, E103,

ICD-10 Finland

2.7

9.4

178

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

9.4

379

2711

11003

ICD-8 Finland

Dermatophytosis, Corporis

+∞

9.4

11008

ICD-8 Finland

Dermatophytosis, Alia

+∞

9.4

11299

ICD-8 Finland

Moniliasis

+∞

9.4

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.6

9.4

186

1142

XPX04

NOMESCO Finland

Angioscopy

4.2

9.4

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

9.4

1846

16173

C08CA05

ATC

nifedipine; systemic

1.5

9.4

280

1890

L01CB

ATC

Podophyllotoxin derivatives

5.1

9.3

L04AC16

ATC

guselkumab; systemic

5.1

9.3

R03AC03

ATC

terbutaline; inhalant

1.3

9.3

638

4960

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

9.3

1421

12144

M43.1

ICD-10 Finland

Spondylolisthesis

1.6

9.3

187

1151

M01AE02

ATC

naproxen; oral, rectal

1.2

9.3

2982

27235

69282

ICD-8 Finland

Other eczema and dermatitis, E microbis

4.0

9.3

H3603, E103,

ICD-10 Finland

2.6

9.3

196

M02AA07

ATC

piroxicam; topical

1.2

9.3

1786

15609

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.6

9.2

199

1247

377

Kela drug reimbursment

Apremilast and dimethyl fumarate (psoriasis)

4.0

9.2

N03AE01

ATC

clonazepam; systemic

1.5

9.2

267

1790

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

9.2

426

3120

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

9.2

213

1359

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.4

9.2

333

2336

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

9.2

323

2253

N48.1

ICD-10 Finland

Balanoposthitis

1.7

9.1

154

906

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.4

9.1

484

3625

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

4.4

9.1

L85.1

ICD-10 Finland

Acquired keratosis [keratoderma] palmaris et plantaris

8.3

9.0

V03AE02

ATC

sevelamer; oral

3.1

9.0

116

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.9

9.0

108

572

B36.9

ICD-10 Finland

Superficial mycosis, unspecified

3.8

9.0

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

4.0

9.0

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

4.0

9.0

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.3

9.0

590

4562

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.7

9.0

160

956

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

9.0

788

6334

SAA04

NOMESCO Finland

Special examination of mouth

1.5

8.9

238

1568

M79.7

ICD-10 Finland

Fibromyalgia

1.8

8.9

140

807

SPAT1139

SPAT

Nutrition survey

1.7

8.9

154

912

D82

ICPC

Teeth/gum disease

1.2

8.9

1885

16607

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.4

8.9

371

2670

OAB43, ,

SPAT

0.8

8.9

980

11762

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

8.9

403

2943

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

2.5

8.9

201

TAKUU, ,

NOMESCO Finland

2.7

8.8

161

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.8

8.8

132

750

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.2

8.8

338

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.7

8.8

158

945

M31.9

ICD-10 Finland

Necrotizing vasculopathy, unspecified

6.8

8.8

D06BB04

ATC

podophyllotoxin; topical

1.6

8.8

195

1231

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

3.1

8.8

118

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1.9

8.8

106

564

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

1.8

8.7

125

701

WVA20, ,

SPAT

1.6

8.7

185

1155

D12

ICPC

Constipation

1.6

8.7

183

1140

L01BB01, ,

ATC

7.2

8.7

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

2.0

8.7

447

L04AA32

ATC

apremilast; oral

4.1

8.7

A02BX02

ATC

sucralfate; oral

1.6

8.7

176

1087

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

8.7

285

1961

OAB44, ,

SPAT

1.4

8.7

475

3575

N05AA02

ATC

levomepromazine; systemic

1.6

8.6

186

1167

P20

ICPC

Memory disturbance

1.3

8.6

690

5479

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.7

8.6

152

906

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

8.6

376

2728

N06AB03

ATC

fluoxetine; oral

1.3

8.6

541

4157

N06AX16

ATC

venlafaxine; oral

1.3

8.6

639

5025

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.2

8.6

303

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.7

8.6

167

1021

L23.2

ICD-10 Finland

Allergic contact dermatitis due to cosmetics

2.7

8.6

158

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

8.6

675

5348

R52.2

ICD-10 Finland

Other chronic pain

1.6

8.6

179

1114

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

2.9

8.6

136

C09CA03

ATC

valsartan; oral

1.4

8.6

473

3565

R55

ICD-10 Finland

Syncope and collapse

1.3

8.6

552

4257

H26.2

ICD-10 Finland

Complicated cataract

2.2

8.5

291

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

8.5

818

6643

WQ020, ,

NOMESCO Finland

9.0

8.5

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

2.8

8.5

142

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.1

8.5

390

R80

ICD-10 Finland

Isolated proteinuria

2.6

8.5

182

CKC12

NOMESCO Finland

Photocoagulation of retina

1.6

8.5

211

1370

R01AD58

ATC

fluticasone, combinations; nasal

1.2

8.4

1170

9894

L01.0

ICD-10 Finland

Impetigo [any organism] [any site]

2.1

8.4

371

H61.2

ICD-10 Finland

Impacted cerumen

1.4

8.4

357

2576

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

2.3

8.4

280

M19.2

ICD-10 Finland

Other secondary arthrosis

2.2

8.4

325

C09CA06

ATC

candesartan; oral

1.2

8.4

1209

10260

S04

ICPC

Lump/swelling localized

1.3

8.4

535

4117

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.0

8.4

405

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.3

8.4

473

3575

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.0

8.4

412

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

4.3

8.4

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

8.4

577

4490

C10AA03

ATC

pravastatin; oral

1.4

8.4

343

2461

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

8.4

364

2639

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.5

8.4

227

1502

ZYC03

NOMESCO Finland

Remote contact, text-based

2.9

8.4

127

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

8.3

401

2956

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.7

8.3

138

808

N05BA01

ATC

diazepam; systemic, rectal

1.3

8.3

597

4671

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

8.3

900

7409

1102A

ICD-9 Finland

Dermatophytosis, Of hand

+∞

8.3

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

8.3

128

734

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

2.2

8.3

327

GDG10

NOMESCO Finland

Bilateral transplantation of lung

8.5

8.3

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

1.7

8.3

138

810

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.5

8.3

284

1972

C02AC05

ATC

moxonidine; oral

1.5

8.3

229

1522

F10.20

ICD-10 Finland

Alcohol dependence currently independent

1.9

8.3

102

547

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.7

8.2

130

751

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.3

8.2

245

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.6

8.2

188

1196

J01DA06

ATC

[U] cefuroxime

1.3

8.2

651

5161

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

3.8

8.2

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.5

8.2

259

1769

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

3.1

8.2

102

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

2.4

8.2

221

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.5

8.2

220

1453

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

8.2

178

1120

XKC03

NOMESCO Finland

Water cystometry

1.7

8.2

133

776

ZYC01, ,

SPAT

1.3

8.1

508

3899

E66.0

ICD-10 Finland

Obesity due to excess calories

2.4

8.1

228

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

2.9

8.1

124

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

1.9

8.1

473

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

2.8

8.1

135

SPAT1360

SPAT

Extensive global examination

1.4

8.1

315

2240

L08

ICPC

Shoulder symptom/complaint

1.2

8.1

1186

10084

SPAT1147

SPAT

Destruction of skin lesion with external methods

2.0

8.1

446

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

3.4

8.1

B02

ICD-10 Finland

Zoster [herpes zoster]

1.5

8.1

213

1402

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

8.0

719

5789

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

8.0

619

4892

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

2.4

8.0

230

C09AA05

ATC

ramipril; oral

1.2

8.0

1294

11106

R13

ICD-10 Finland

Dysphagia

1.4

8.0

342

2474

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

8.0

1364

11767

N04BC05

ATC

pramipexole; oral

1.4

8.0

353

2568

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.2

8.0

300

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.4

8.0

366

2679

L20.8

ICD-10 Finland

Other atopic dermatitis

2.3

8.0

268

69299

ICD-8 Finland

Other eczema and dermatitis, Due to other and unspecified cause

3.8

8.0

B01AF02

ATC

apixaban; oral

1.3

7.9

692

5553

L13.0

ICD-10 Finland

Dermatitis herpetiformis

3.3

7.9

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

7.9

261

1799

C01DA14

ATC

isosorbide mononitrate; oral

1.3

7.9

761

6181

T79.3

ICD-10 Finland

Post-traumatic wound infection, not elsewhere classified

2.0

7.9

422

L23.3

ICD-10 Finland

Allergic contact dermatitis due to drugs in contact with skin

2.9

7.9

126

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

7.9

759

6165

SPAT1151

SPAT

Treatment of major wounds

2.2

7.9

295

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.3

7.9

446

3375

RJ511, ,

NOMESCO Finland

4.6

7.9

A10BA02

ATC

metformin; oral

1.2

7.8

1502

13089

AN1

Coronary angiography

1.3

7.8

547

4265

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.5

7.8

221

1476

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.8

7.8

121

696

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.4

7.8

202

N05AX12

ATC

aripiprazole; systemic

1.6

7.8

165

1032

H02AB08

ATC

triamcinolone; systemic

3.4

7.8

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

2.0

7.8

390

ZZR00

NOMESCO Finland

Flap of skin

1.8

7.7

107

595

B01AB04

ATC

dalteparin; parenteral

1.5

7.7

233

1577

C10AA01

ATC

simvastatin; oral

1.2

7.7

2201

19819

M54.3

ICD-10 Finland

Sciatica

1.4

7.7

279

1957

Z94.3

ICD-10 Finland

Heart and lungs transplant status

45.0

7.7

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

7.7

425

3203

Q82.82

ICD-10 Finland

Inherited keratosis palmaris et plantaris

15.0

7.7

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

7.7

206

1360

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.6

7.7

191

1240

J01FA15

ATC

telithromycin; oral

1.3

7.7

444

3369

90621, ,

NOMESCO Finland

4.3

7.7

QDA10

NOMESCO Finland

Incision of skin of lower limb

2.6

7.7

162

WX725

NOMESCO Finland

Noninvasive ventilation

1.4

7.6

272

1903

NH1AD

NOMESCO Finland

Ankle and foot CT

1.8

7.6

114

649

Z49.2

ICD-10 Finland

Other dialysis

2.5

7.6

174

J01CR50

ATC

combinations of penicillins; systemic

4.5

7.6

L70.0

ICD-10 Finland

Acne vulgaris

1.9

7.6

483

N05BA04

ATC

oxazepam; oral

1.2

7.6

1261

10838

L15

ICPC

Knee symptom/complaint

1.2

7.6

1249

10727

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

1.6

7.6

160

999

B01AF01

ATC

rivaroxaban; oral

1.3

7.6

637

5086

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.1

7.6

339

L43

ICD-10 Finland

Lichen planus

2.2

7.6

267

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

7.6

326

2359

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.6

7.6

154

953

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.6

7.6

159

992

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.7

7.6

142

861

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

2.4

7.6

217

QXB05, ,

SPAT

2.3

7.6

242

NC1AE

NOMESCO Finland

Elbow ultrasound examination

6.7

7.6

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.7

7.6

131

778

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

7.6

530

4135

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

7.6

1387

12035

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

7.6

236

1610

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

2.4

7.6

199

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.5

7.6

216

1447

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

7.5

337

2456

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.5

7.5

SPAT1251

SPAT

Organisation of medication

1.6

7.5

150

925

B05DB

ATC

Hypertonic solutions

2.6

7.5

158

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

1.8

7.5

109

616

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

1.6

7.5

168

1066

QBB10, ,

SPAT

2.0

7.5

375

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.6

7.5

183

1185

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.2

7.5

1130

9629

TFJ02

NOMESCO Finland

Muscle biopsy of heart

4.2

7.5

D69.0

ICD-10 Finland

Allergic purpura

2.8

7.5

130

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

1.7

7.5

121

706

PD4DG

NOMESCO Finland

Very extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

3.0

7.4

103

WVA30, ,

SPAT

1.4

7.4

328

2385

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.6

7.4

179

1155

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.3

7.4

643

5156

M01CB03

ATC

auranofin; oral

2.7

7.4

136

N18.0

ICD-10 Finland

End-stage renal disease

2.3

7.4

238

6960A

ICD-9 Finland

Psoriasis and similar disorders, Psoriatic arthropathy

4.4

7.4

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

2.6

7.4

159

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

7.4

1039

8787

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.2

7.4

270

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.6

7.4

175

1124

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.4

7.4

344

2524

WQ021, ,

NOMESCO Finland

6.4

7.4

I95.1

ICD-10 Finland

Orthostatic hypotension

1.5

7.4

187

1221

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

2.9

7.4

109

B37.00

ICD-10 Finland

Acute pseudomembraneuous candidal stomatitis

6.0

7.4

U05

ICPC

Urination problems other

1.4

7.3

265

1860

R31

ICD-10 Finland

Unspecified haematuria

1.3

7.3

531

4163

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

2.4

7.3

190

D11AX14

ATC

[U] tacrolimus

3.0

7.3

L04AC05

ATC

ustekinumab; parenteral

3.0

7.3

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

7.3

185

1208

11005

ICD-8 Finland

Dermatophytosis, Manuum

+∞

7.3

K05.30

ICD-10 Finland

Periodontitis complex

1.3

7.3

754

6174

K30

ICD-10 Finland

Functional dyspepsia

1.3

7.3

517

4041

GD1BT

NOMESCO Finland

Biopsy of lung with X-ray guidance

6.8

7.3

A10BB12

ATC

glimepiride; oral

1.4

7.3

313

2267

Z49.0

ICD-10 Finland

Preparatory care for dialysis

2.2

7.3

253

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.4

7.2

203

NH3AE

NOMESCO Finland

Feet ultrasound examination

3.8

7.2

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.5

7.2

225

1534

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.7

7.2

124

735

L01AA01

ATC

cyclophosphamide; systemic

3.4

7.2

PARO, ,

NOMESCO Finland

3.4

7.2

SDA03

NOMESCO Finland

Periodontal treatment

1.2

7.2

2075

18674

H05AA02

ATC

teriparatide; parenteral

3.3

7.2

SPA50

NOMESCO Finland

Determination of bite and dental arch location

1.9

7.2

408

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.7

7.2

137

835

R15

ICD-10 Finland

Faecal incontinence

1.7

7.2

122

721

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

1.7

7.2

129

774

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

1.7

7.2

130

782

XQ801

NOMESCO Finland

Intracutantest

3.0

7.2

100

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

7.3

7.2

SCA01

NOMESCO Finland

Preventive oral health care, short

1.2

7.2

1352

11753

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

2.2

7.2

248

R03AC13

ATC

formoterol; inhalant

1.5

7.2

218

1480

D11

ICPC

Diarrhoea

1.3

7.2

535

4210

K50.9

ICD-10 Finland

Crohn disease, unspecified

2.0

7.2

354

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

1.5

7.2

209

1407

I84.5

ICD-10 Finland

External hemorrhoids without complication

1.7

7.2

127

760

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

2.2

7.1

242

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

2.5

7.1

168

K11.2

ICD-10 Finland

Sialoadenitis

1.6

7.1

151

945

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

1.6

7.1

164

1047

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

2.3

7.1

217

318

Kela drug reimbursment

Teriparatide

3.1

7.1

R03DC01

ATC

zafirlukast; oral

2.0

7.1

348

K08.80

ICD-10 Finland

Toothache NOS

1.3

7.1

392

2955

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

2.5

7.1

163

TNC11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in elbow joint

4.1

7.1

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

7.1

225

1542

C03AA03

ATC

hydrochlorothiazide; oral

1.3

7.1

407

3089

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

2.5

7.1

169

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.4

7.1

287

2059

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.6

7.0

159

1011

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.3

7.0

510

3997

SPD00

NOMESCO Finland

Mucosa borne complete denture

2.2

7.0

263

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

2.6

7.0

146

D07XB01

ATC

flumetasone; topical

2.6

7.0

146

N18.8

ICD-10 Finland

Other chronic renal failure

1.7

7.0

117

689

N05AH03

ATC

olanzapine; systemic

1.4

7.0

280

2003

TPH04, ,

SPAT

2.1

7.0

290

D01

ICPC

Abdominal pain/cramps general

1.3

7.0

562

4466

TNG10

NOMESCO Finland

Puncture of knee

2.2

7.0

264

L28.2

ICD-10 Finland

Other prurigo

3.2

7.0

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

1.7

7.0

118

698

SPAT1361

SPAT

Collection of tissue sample

3.3

7.0

RJ190, ,

NOMESCO Finland

4.4

6.9

C07AG02

ATC

carvedilol; oral

1.4

6.9

274

1956

L12

ICPC

Hand/finger symptom/complaint

1.2

6.9

835

6951

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

2.6

6.9

147

L20

ICD-10 Finland

Atopic dermatitis

1.7

6.9

122

729

PE1AT

NOMESCO Finland

Femoral artery PTA

2.1

6.9

298

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.4

6.9

242

1690

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

2.5

6.9

171

XCK00

NOMESCO Finland

Perimetry

1.4

6.9

272

1942

N05AH02

ATC

clozapine; systemic

1.9

6.9

415

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.3

6.9

512

4029

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.2

6.9

253

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

6.9

1164

10021

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.0

6.9

360

SPAT1167

SPAT

Insertion of urinary catheter

1.6

6.8

147

924

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.6

6.8

139

862

A10AD01

ATC

insulin (human); parenteral

1.9

6.8

388

SPAT1293

SPAT

Other function in accordance with rehabilitation guidance nomenclature

2.8

6.8

114

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

2.8

6.8

114

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.4

6.8

178

R33

ICD-10 Finland

Retention of urine

1.3

6.8

409

3123

L60

ICD-10 Finland

Nail disorders

2.5

6.8

172

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

1.5

6.8

179

1179

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.3

6.8

387

2932

E14.1

ICD-10 Finland

Unspecified diabetes mellitus, with ketoacidosis

4.1

6.8

B08.1

ICD-10 Finland

Molluscum contagiosum

3.8

6.8

G04CA01

ATC

alfuzosin; oral

1.2

6.8

704

5765

K04.0

ICD-10 Finland

Pulpitis

1.3

6.8

397

3020

L40.4

ICD-10 Finland

Guttate psoriasis

3.0

6.8

M02AA10

ATC

ketoprofen; topical

1.2

6.8

747

6158

H57.1

ICD-10 Finland

Ocular pain

1.6

6.8

169

1100

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

2.6

6.8

137

R21

ICPC

Throat symptom/complaint

1.2

6.8

923

7781

A06AC51

ATC

ispaghula, combinations; oral

1.5

6.8

202

1367

J01XX08

ATC

linezolid; systemic

2.6

6.8

149

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

2.7

6.7

126

L88

ICD-10 Finland

Pyoderma gangrenosum

4.3

6.7

0350X

ICD-9 Finland

Erysipelas[ERYSIPELAS ALIA DEFINITA SEU NUD]

2.5

6.7

161

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

1.8

6.7

504

N05BA06

ATC

lorazepam; systemic, sublingual

1.5

6.7

227

1574

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

3.1

6.7

R4110, ,

SPAT

1.3

6.7

649

5272

NHG82

NOMESCO Finland

Fusion of other tarsal joint

2.3

6.7

223

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

6.7

1931

17359

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.5

6.7

192

1288

K13.78

ICD-10 Finland

Other change in the oral mucosa

1.7

6.7

116

690

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

3.4

6.7

M54.2

ICD-10 Finland

Cervicalgia

1.3

6.7

373

2819

B37.0

ICD-10 Finland

Candidal stomatitis

2.3

6.7

211

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.7

6.7

119

714

M20.5

ICD-10 Finland

Other deformities of toe(s) (acquired)

2.5

6.7

150

D01AA02

ATC

natamycin; topical

1.8

6.7

513

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.5

6.6

227

1578

IGY99, ,

SPAT

1.9

6.6

406

NDG30

NOMESCO Finland

Fusion of wrist, total

3.0

6.6

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

1.9

6.6

456

TQW40, ,

SPAT

1.3

6.6

495

3896

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

6.4

6.6

D01BA01

ATC

griseofulvin; oral

6.4

6.6

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

6.6

442

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

2.8

6.6

116

Z01.7

ICD-10 Finland

Laboratory examination

1.2

6.6

813

6781

N08.2

ICD-10 Finland

Glomerular disorders in blood diseases and disorders involving the immune mechanism

4.0

6.6

QAE15

NOMESCO Finland

Excision of other superficial lesion of skin from head and neck

4.0

6.6

EC1VA, ,

NOMESCO Finland

1.5

6.6

224

1555

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

2.6

6.6

139

N02AC04

ATC

dextropropoxyphene; oral

1.6

6.6

153

980

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

6.6

295

2152

QCH00

NOMESCO Finland

Avulsion of finger nail

7.8

6.6

ZX120, ,

SPAT

1.9

6.6

372

K83.0

ICD-10 Finland

Cholangitis

1.9

6.6

386

XCH00

NOMESCO Finland

Eye pressure measurement

1.5

6.6

220

1523

R5110, ,

SPAT

1.3

6.6

408

3131

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

3.6

6.6

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.7

6.6

124

755

L21

ICD-10 Finland

Seborrhoeic dermatitis

1.8

6.6

479

SPAT1284

SPAT

Extensive health certificate

1.7

6.6

119

717

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

1.7

6.6

120

725

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.5

6.6

172

1133

S01BA01

ATC

dexamethasone; ophthalmic

1.6

6.6

144

911

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

1.7

6.6

103

597

A10BH05

ATC

linagliptin; oral

1.4

6.6

246

1741

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.5

6.5

212

1459

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

1.9

6.5

451

L04AA11

ATC

[U] etanercept

3.3

6.5

NJ3CG

NOMESCO Finland

Extensive MRI examination of extremities with median high magnet

3.3

6.5

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

4.2

6.5

K64.1

ICD-10 Finland

Second degree haemorrhoids

1.7

6.5

112

665

S90.1

ICD-10 Finland

Contusion of toe(s) without damage to nail

1.8

6.5

531

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.5

6.5

204

1394

A07AA09

ATC

vancomycin; oral

2.0

6.5

346

E66

ICD-10 Finland

Obesity

1.4

6.5

235

1651

K29

ICPC

Cardiovascular sympt/complt other

1.5

6.5

210

1444

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.5

6.5

175

1159

TQW11

NOMESCO Finland

Vacuum treatment of wound

1.8

6.5

561

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

2.2

6.5

239

WX408

NOMESCO Finland

General anesthesy, balanced

1.2

6.5

1280

11160

U04

ICPC

Incontinence urine

1.4

6.5

263

1887

03599

ICD-8 Finland

Erysipelas

3.0

6.5

R04.0

ICD-10 Finland

Epistaxis

1.3

6.5

364

2754

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.6

6.5

133

828

N05CD02

ATC

nitrazepam; oral

1.9

6.5

368

T18.1

ICD-10 Finland

Foreign body in oesophagus

2.3

6.5

189

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.5

6.5

163

1065

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.0

6.5

313

L86

ICPC

Back syndrome with radiating pain

1.4

6.4

283

2060

J45.8

ICD-10 Finland

Mixed asthma

1.6

6.4

136

853

PG1XE

NOMESCO Finland

Other ultrasound examination of blood vessel not elsewhere classified

2.5

6.4

153

L30

ICD-10 Finland

Other dermatitis

1.7

6.4

109

646

J01MA06

ATC

norfloxacin; oral

1.3

6.4

542

4334

WX882

NOMESCO Finland

High dependency care

1.6

6.4

134

838

S51

ICD-10 Finland

Open wound of forearm

3.3

6.4

M14.6

ICD-10 Finland

Neuropathic arthropathy

7.4

6.4

L01BB05

ATC

fludarabine; systemic

7.4

6.4

R1250

NOMESCO Finland

Evaluation of functional capability

1.7

6.4

115

692

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.4

6.4

250

1783

K29.7

ICD-10 Finland

Gastritis, unspecified

1.5

6.4

159

1036

R52.1

ICD-10 Finland

Chronic intractable pain

2.3

6.4

209

M10.0

ICD-10 Finland

Idiopathic gout

1.5

6.4

178

1189

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

1.9

6.4

405

H36.01

ICD-10 Finland

Diabetic maculopathy

1.9

6.4

356

291

Kela drug reimbursment

Tofacitinib

3.7

6.4

PEP25

NOMESCO Finland

Percutaneous plastic repair of superficial femoral artery

3.7

6.4

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.6

6.3

151

974

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

1.6

6.3

127

786

M18.9

ICD-10 Finland

Arthrosis of first carpometacarpal joint, unspecified

2.0

6.3

295

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

6.3

1472

13009

SBB10

NOMESCO Finland

Dental impressions

1.4

6.3

287

2101

D07XA01

ATC

hydrocortisone; topical

3.6

6.3

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

1.7

6.3

103

604

F40.2

ICD-10 Finland

Specific (isolated) phobias

2.8

6.3

108

G63.2

ICD-10 Finland

Diabetic polyneuropathy

2.9

6.3

S81

ICD-10 Finland

Open wound of lower leg

2.9

6.3

B37.02

ICD-10 Finland

Chronic hyperplastic candidal stomatitis

11.0

6.3

N02BF02

ATC

pregabalin; oral

1.4

6.3

315

2342

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.3

6.3

368

2802

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1.7

6.3

560

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

1.9

6.3

358

U02

ICPC

Urinary frequency/urgency

1.2

6.3

646

5288

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

2.9

6.3

H36.09

ICD-10 Finland

Diabetic retinopathy (E10-E14+ with common fourth character .3)

2.9

6.3

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.1

6.2

263

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

2.0

6.2

317

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.7

6.2

107

636

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

2.1

6.2

250

A01AB04

ATC

amphotericin B; local oral

1.5

6.2

185

1252

N50.9

ICD-10 Finland

Disorder of male genital organs, unspecified

2.7

6.2

120

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

1.8

6.2

473

R74

ICPC

Upper respiratory infection acute

1.2

6.2

1511

13395

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

2.3

6.2

205

S86.0

ICD-10 Finland

Injury of Achilles tendon

1.6

6.2

127

790

EMB10

NOMESCO Finland

Tonsillectomy

1.5

6.2

206

1425

WW200, ,

SPAT

1.2

6.2

1531

13588

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

2.3

6.2

180

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

6.2

284

2081

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

6.2

484

3832

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

1.8

6.2

481

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

1.7

6.2

106

630

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.4

6.2

300

2220

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

2.0

6.2

298

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.3

6.2

468

3692

L95

ICPC

Osteoporosis

1.5

6.2

159

1045

K92.1

ICD-10 Finland

Melaena

1.4

6.1

253

1821

J01CF02

ATC

cloxacillin; systemic

1.7

6.1

100

586

L71.0

ICD-10 Finland

Perioral dermatitis

2.0

6.1

319

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.4

6.1

230

1628

M10

ICD-10 Finland

Gout

1.4

6.1

227

1603

M80.8

ICD-10 Finland

Other osteoporosis with pathological fracture

2.9

6.1

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

1.9

6.1

396

D23.0

ICD-10 Finland

Benign neoplasm: Skin of lip

3.2

6.1

L04AC07

ATC

tocilizumab; parenteral

3.2

6.1

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.6

6.1

144

927

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.2

6.1

213

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.1

6.1

2154

19624

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.5

6.1

168

1120

N05AX08

ATC

risperidone; systemic

1.3

6.1

373

2859

R44

ICPC

Respiratory, Preventive immunization/medic

1.9

6.1

341

L29

ICD-10 Finland

Pruritus

1.9

6.1

341

L01

ICPC

Neck symptom/complaint

1.2

6.1

748

6240

SXC05

NOMESCO Finland

Other oral or dental procedure

1.4

6.1

289

2132

L05

ICPC

Flank/axilla symptom/complaint

1.4

6.1

301

2235

P03

ICPC

Feeling depressed

1.3

6.1

402

3115

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

6.1

1862

16796

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

6.1

562

4545

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

1.9

6.1

398

SPAT1059

SPAT

Spirometry at the office

1.4

6.0

227

1608

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.4

6.0

211

1475

N02AJ13

ATC

tramadol and paracetamol; systemic

1.7

6.0

103

612

RD211, ,

NOMESCO Finland

1.5

6.0

190

1302

XW000

NOMESCO Finland

Bone marrow biopsy

1.5

6.0

190

1302

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.7

6.0

552

R03DA04

ATC

theophylline; systemic, rectal

1.4

6.0

209

1459

PHD77

NOMESCO Finland

Resection of short saphenous vein

2.4

6.0

164

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.0

6.0

301

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.5

6.0

196

1352

SPAT1304

SPAT

Counselling and guidance related to ageing

1.4

6.0

310

2316

G04CB01

ATC

finasteride; oral

1.3

6.0

585

4757

K05.31

ICD-10 Finland

Periodontitis pronounced

1.3

6.0

535

4306

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000494) Fungus identified in Specimen by Culture

2234

6841

4.49

307.65

1.7

1.4

—

(3006315) Basophils [#/volume] in Blood

3941

29267

1.91

129.51

9.5

6.3

0.04

e9/l

0.05

3553

25034

(3001604) Monocytes [#/volume] in Blood

3928

29183

1.91

128.39

9.5

6.3

0.60

e9/l

0.34

3543

24951

(3007853) Bacteria identified in Skin by Aerobe culture

1325

6826

2.19

125.72

2.3

1.8

—

(3013115) Eosinophils [#/volume] in Blood

4013

30131

1.90

125.65

9.8

6.5

0.20

e9/l

1.31

3665

26203

(3013650) Neutrophils [#/volume] in Blood by Automated count

4246

32512

1.92

124.65

12.5

9.8

4.29

4.16

e9/l

2.71

3869

28074

(3019198) Lymphocytes [#/volume] in Blood

3972

29826

1.88

123.12

9.6

6.4

1.85

1.90

e9/l

1.40

3642

26137

(40768443) Skin Pathology biopsy report

620

2492

2.65

101.54

1.4

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1961

12604

1.80

93.71

7.6

4.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5110

43165

1.94

92.85

11.1

8.5

81.01

79.78

u/l

0.62

4899

41067

(3024561) Albumin [Mass/volume] in Serum or Plasma

3424

25969

1.69

88.50

6.5

5.4

35.13

35.57

g/l

4.51

3262

24396

(3023368) Bacteria identified in Blood by Culture

2355

16601

1.67

77.15

5.4

4.5

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

4838

41101

1.74

74.33

6.5

4.4

12.88

12.00

mm/h

3.72

4585

38526

(3019150) Specific gravity of Urine by Refractometry

1931

13072

1.69

72.95

6.0

4.0

1.02

1.13

kg/l

0.50

1304

8774

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2521

18273

1.63

72.78

3.2

2.7

58.21

65.20

u/l

0.84

2354

17021

(3029937) Albumin [Presence] in Urine by Test strip

2311

16408

1.64

72.40

6.1

4.0

0.00

estimate

0.52

716

5706

(3035350) Ketones [Presence] in Urine by Test strip

3744

29898

1.61

72.04

5.5

3.8

1.98

4.45

estimate

0.58

763

6381

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3648

29023

1.60

70.65

9.8

7.6

1.21

mmol/l

1.93

3219

25163

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1107

6433

1.87

70.60

11.3

6.9

—

(3009261) Glucose [Presence] in Urine by Test strip

3753

30078

1.61

70.33

5.5

3.9

0.02

0.06

estimate

0.45

713

5956

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

859

4611

2.00

69.35

3.0

2.8

63.54

66.08

ml/min/173m2

0.99

400

1956

(3021601) Nitrite [Presence] in Urine by Test strip

3695

29577

1.60

68.96

5.5

3.8

0.00

estimate

1.60

746

6242

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3753

30184

1.59

68.36

7.8

6.9

11.23

12.00

umol/l

3.40

3613

28847

(3020891) Body temperature

594

2795

2.24

67.71

6.3

4.5

36.96

36.92

°c

2.07

583

2765

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1532

10005

1.70

64.88

2.2

1.9

—

(3015736) pH of Urine

3074

23781

1.57

64.82

4.9

3.4

6.32

6.21

6.60

1759

13294

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2908

22285

1.56

63.45

5.5

3.8

2.16

0.15

estimate

1.04

638

5132

(3042936) Bacteria identified in Isolate by Culture

1337

8460

1.74

63.33

2.6

2.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2455

18123

1.58

63.00

2.6

2.2

216.06

224.63

u/l

0.13

2338

17165

(3019069) Monocytes/Leukocytes in Blood

3394

26976

1.55

62.55

9.9

6.7

8.87

8.98

1.42

3216

25299

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3288

26007

1.55

61.51

9.4

6.9

1.20

1.21

mmol/l

3.09

3082

24142

(3006504) Eosinophils/Leukocytes in Blood

3375

26902

1.54

60.56

9.7

6.6

2.90

2.86

0.42

3197

25220

(3018010) Neutrophils/Leukocytes in Blood

3387

27065

1.54

59.74

9.5

6.4

57.98

57.52

1.42

3253

25852

(3002030) Lymphocytes/Leukocytes in Blood

3430

27559

1.53

58.42

9.8

6.6

27.00

27.37

1.16

3271

26113

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

2754

21110

1.54

58.34

5.0

3.5

—

1.41

—

(3022096) Basophils/Leukocytes in Blood

3360

26889

1.53

58.21

9.8

6.7

0.69

0.68

0.98

3182

25194

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3175

25122

1.53

57.86

3.0

2.4

76.85

77.09

nmol/l

0.20

2910

22772

(3031040) Bacteria [#/volume] in Urine by Automated count

4297

36329

1.56

57.51

6.0

4.7

286.51

1400.18

e6/l

2.73

517

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2099

15288

1.56

55.24

2.7

2.4

2.93

2.80

mg/l

1.81

1852

13264

(3008152) Bicarbonate [Moles/volume] in Arterial blood

699

3768

1.96

55.02

7.5

6.9

24.60

24.46

mmol/l

0.37

674

3611

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1125

7027

1.73

54.93

2.1

1.9

—

(3037467) Urinalysis macro (dipstick) panel - Urine

4440

37998

1.56

54.59

6.0

4.5

2.51

2.52

—

(3037522) Nuclear Ab [Titer] in Serum

1220

7812

1.70

54.32

1.5

1.4

481.64

507.47

titre

0.22

274

1625

(3032080) INR in Blood by Coagulation assay

3366

27186

1.51

54.13

20.5

15.8

1.30

1.28

inr

1.39

2885

22823

(3011397) Hemoglobin [Presence] in Urine by Test strip

1902

13626

1.56

53.49

5.7

3.7

0.18

0.00

149

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1172

7472

1.70

52.88

2.0

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

4042

33999

1.52

52.84

6.9

5.3

6.89

6.76

mmol/l

2.15

3877

32365

(3026493) Urate [Moles/volume] in Serum or Plasma

2127

15659

1.54

52.74

3.6

2.8

356.51

350.08

umol/l

1.98

1885

13853

(3000850) Epithelial cells [#/volume] in Urine

1863

13347

1.56

52.11

3.7

2.8

4.80

4.89

e6/l

0.12

1762

12182

(3019977) pH of Arterial blood

1138

7238

1.70

51.68

7.3

8.2

7.41

7.42

0.41

665

3944

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2347

17743

1.51

50.94

3.9

3.3

1584.10

1449.09

ng/l

0.67

2033

15363

(3003396) Base excess in Arterial blood by calculation

1127

7187

1.69

50.56

7.2

8.1

1.13

0.88

mmol/l

1.16

953

5899

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

158

429

3.75

50.23

1.9

1.5

21.39

23.39

u/ml

0.20

(3018418) pH of Serum or Plasma

2304

17393

1.51

50.13

5.9

4.3

7.40

0.92

1764

12473

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1131

7255

1.68

49.52

7.3

8.1

5.12

5.09

kpa

0.44

1094

6997

(3016502) Oxygen saturation in Arterial blood

1034

6480

1.71

49.38

7.5

8.5

95.10

95.58

1.62

1003

6266

(3027801) Oxygen [Partial pressure] in Arterial blood

1130

7254

1.68

49.32

7.4

8.1

11.72

12.41

kpa

4.36

1093

6996

(3026008) Bacteria identified in Urine by Culture

2192

16438

1.51

48.93

3.9

3.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1278

8496

1.63

48.55

7.9

7.6

103.81

104.39

mmol/l

4.01

1278

8491

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

571

3025

1.98

46.97

4.8

4.0

51.54

47.62

3.49

565

2974

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5818

53902

1.94

46.86

25.2

16.8

25.06

25.22

mg/l

0.13

5140

44789

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4730

41635

1.53

45.82

5.0

4.2

14.91

14.80

pmol/l

2.35

4396

38243

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

833

5025

1.76

45.30

2.7

2.4

6.33

7.87

ug/l

1.19

734

4457

(3022948) Iron [Moles/volume] in Serum or Plasma

1470

10256

1.56

45.09

3.4

2.7

12.60

13.01

umol/l

1.45

1385

9603

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3175

26017

1.44

43.15

3.7

3.1

135.94

138.49

ug/l

0.23

2985

24321

(3015377) Calcium [Moles/volume] in Serum or Plasma

2490

19562

1.45

42.14

3.6

2.35

mmol/l

1.00

2277

17824

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2754

22056

1.44

41.96

4.8

3.8

37.64

74.41

ng/l

1.12

2075

15771

(3002173) Hemoglobin [Mass/volume] in Arterial blood

947

6041

1.67

41.70

7.9

9.0

122.42

121.75

g/l

0.41

927

5909

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1183

7981

1.59

41.52

9.0

6.4

1.06

1.04

mmol/l

1.61

1109

7472

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

717

4251

1.77

41.17

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1706

12515

1.50

40.73

1.9

1.8

1.20

1.30

mg/l

0.50

1340

9751

(3005322) IgE [Units/volume] in Serum or Plasma

620

3544

1.83

40.18

1.5

1.3

440.84

259.30

u/ml

1.54

578

3281

(3009445) Proteinase 3 Ab [Units/volume] in Serum

481

2533

1.97

40.08

1.8

1.5

17.05

16.70

iu/ml

0.02

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1371

9637

1.54

39.96

3.4

2.7

2.31

2.30

g/l

0.34

1285

8947

(3026389) Candida sp identified in Specimen by Organism specific culture

189

664

2.90

39.61

1.6

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

2154

16624

1.45

39.35

1.9

1.7

19.48

19.91

nmol/l

0.71

1878

14184

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

472

2488

1.97

39.20

2.2

1.9

2.55

2.49

ug/l

0.03

426

2220

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3092

25491

1.41

39.03

2.3

2.1

94.19

95.12

pmol/l

0.50

1773

13799

(3005719) IgG [Mass/volume] in Serum or Plasma

740

4502

1.73

38.69

3.5

2.8

10.30

10.65

g/l

1.47

693

4152

(3010375) cycloSPORINE [Mass/volume] in Blood

101

242

4.22

38.21

29.7

27.5

101.83

111.82

ug/l

0.82

200

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

420

2145

2.03

38.13

1.4

1.3

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

963

6308

1.62

37.88

5.2

4.0

5.86

5.81

kpa

0.91

943

6147

(3015171) Extractable nuclear Ab [Units/volume] in Serum

417

2138

2.02

37.44

1.3

1.2

0.93

1.11

u/ml

0.11

175

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

131

383

3.47

37.35

1.5

1.3

742.73

264.48

titre

0.50

(3024354) Oxygen [Partial pressure] in Venous blood

826

5240

1.66

36.83

4.5

3.3

4.61

4.58

kpa

0.17

804

5097

(3019309) Folate [Moles/volume] in Red Blood Cells

1348

9605

1.51

36.41

1.8

1274.94

1146.54

nmol/l

4.28

1046

7307

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

127

372

3.46

36.12

1.4

1.3

108.33

64.64

titre

0.99

(3002582) Erythrocytes [#/volume] in Urine

2422

19309

1.41

36.10

4.5

3.5

74.38

81.65

e6/l

0.09

2021

14793

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

237

985

2.46

35.62

1.6

1.4

8.47

12.88

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

364

1810

2.07

35.52

1.6

1.5

2.01

6.47

iu/ml

0.52

350

(3023420) DNA double strand Ab [Units/volume] in Serum

429

2265

1.96

35.39

2.0

1.8

4.76

6.59

iu/ml

1.08

122

534

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5412

49849

1.58

35.35

6.2

5.2

1.91

1.93

mu/l

0.46

5067

46129

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1665

12439

1.46

35.31

1.4

1.3

1.94

1.93

u/ml

0.01

482

3314

(3019550) Sodium [Moles/volume] in Serum or Plasma

5859

55084

1.82

35.29

28.1

19.9

139.50

139.68

mmol/l

6.08

5789

54079

(3030981) Hyaline casts [#/volume] in Urine by Automated count

789

5004

1.66

35.11

2.8

2.5

0.46

0.49

e6/l

0.10

751

4809

(3009508) Creatinine [Moles/volume] in Urine

2553

20631

1.40

34.76

4.1

3.5

7.44

7.77

mmol/l

3.31

2218

17514

(3017732) Neutrophils [#/volume] in Blood

1071

7327

1.56

34.72

3.9

3.2

4.78

4.64

e9/l

0.23

942

6355

(3036481) Cortisol [Moles/volume] in Serum or Plasma

832

5366

1.63

34.62

2.8

2.3

344.90

379.40

nmol/l

5.84

771

4972

(3020630) Protein [Mass/volume] in Serum or Plasma

807

5175

1.64

34.34

2.7

65.78

66.41

g/l

1.40

746

4752

(3012544) pH of Venous blood

956

6403

1.58

33.95

5.2

4.0

7.37

7.38

0.79

575

3692

(3012516) Albumin [Mass/volume] in Urine

2416

19402

1.40

33.87

4.1

3.5

57.39

50.25

mg/l

0.75

1696

12747

(3023103) Potassium [Moles/volume] in Serum or Plasma

5862

55216

1.80

33.74

28.3

20.1

4.00

3.98

mmol/l

6.30

5782

54124

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1383

10047

1.48

33.60

4.5

3.5

0.81

0.82

mmol/l

0.41

1317

9487

(3014111) Lactate [Moles/volume] in Serum or Plasma

861

5650

1.61

33.29

7.3

8.2

1.38

1.33

mmol/l

0.75

851

5541

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1246

8896

1.50

32.90

3.5

2.7

21.49

22.77

3.06

1175

8300

(3002032) Base excess in Venous blood by calculation

920

6149

1.58

32.88

5.3

4.0

1.64

1.79

mmol/l

0.53

825

5357

(3028026) IgM [Mass/volume] in Serum or Plasma

589

3532

1.74

32.17

2.1

2.0

1.28

1.33

g/l

0.15

541

3248

(3017143) Hepatitis C virus Ab [Presence] in Serum

939

6343

1.56

31.97

1.9

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

269

1247

2.21

31.43

8.9

5.5

902.94

1788.17

iu/ml

0.32

184

(3026250) Tacrolimus [Mass/volume] in Blood

257

3.78

31.25

49.8

39.4

7.48

7.20

ug/l

0.45

231

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

347

1778

2.01

31.15

1.9

1.6

1.19

g/l

0.01

338

1695

(3027945) Reticulocytes/Erythrocytes in Blood

1023

7099

1.53

30.72

3.3

2.6

1.80

1.78

0.24

907

6345

(3017181) Myelocytes/Leukocytes in Blood

814

5378

1.59

30.40

6.1

4.4

0.96

0.93

0.08

328

1663

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

391

2108

1.91

30.25

2.8

2.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2429

19780

1.37

30.24

4.8

4.2

10.92

9.00

mg/mmol

0.97

1653

12661

(3018095) Leukocytes [#/volume] in Urine

2630

21694

1.36

30.14

5.1

4.1

98.67

95.27

e6/l

0.06

2070

15476

(3000991) Gas panel - Venous blood

820

5448

1.58

29.87

9.1

9.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1034

7240

1.51

29.67

4.9

4.5

251.86

242.07

u/l

0.74

988

6894

(46235355) HIV 1 and 2 tests - Meaningful Use set

1289

9458

1.46

29.19

2.0

1.9

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

222

980

2.31

29.17

3.7

2.8

1897.38

2160.76

u/ml

—

(3030467) Casts [#/volume] in Urine by Automated count

2083

16640

1.37

28.89

4.2

3.4

0.39

0.42

e6/l

0.18

1683

12237

(3002179) Metamyelocytes/Leukocytes in Blood

775

5122

1.58

28.81

5.8

4.3

0.72

0.71

0.06

301

1586

(3007164) IgA [Mass/volume] in Serum or Plasma

1466

11063

1.42

28.39

1.7

1.5

2.58

2.51

g/l

0.37

990

6842

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3102

26414

1.34

28.10

3.3

2.9

—

estimate

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

328

1712

1.97

27.92

2.0

1.6

0.23

0.24

g/l

1.39

319

1626

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

678

4372

1.62

27.90

5.6

4.1

107.39

94.53

ng/l

2.17

611

3778

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

307

1566

2.01

27.90

1.8

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

465

2730

1.76

27.25

4.2

3.5

25.21

25.16

mmol/l

0.13

452

2636

(3048689) Calprotectin [Mass/mass] in Stool

990

6981

1.50

27.24

2.8

2.5

155.45

143.97

ug/g

0.38

821

5615

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5963

56863

1.79

27.21

17.5

12.4

26.80

27.09

u/l

0.55

5844

55275

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

841

5737

1.54

27.07

2.3

0.21

g/l

0.57

770

5361

(36304419) Bacteria [Presence] in Urine

1979

15823

1.36

26.82

4.1

3.3

0.00

40.28

estimate

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1476

11257

1.41

26.64

3.0

3.1

2.45

mmol/l

0.27

1333

10099

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1336

10018

1.42

26.56

1.4

1.3

37.08

31.28

iu/ml

0.65

431

3006

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

297

1524

2.00

26.54

1.7

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

808

5493

1.54

26.38

3.0

2.6

71.00

69.25

e9/l

0.60

632

4023

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5992

57338

1.79

25.36

31.2

21.9

82.91

80.18

umol/l

5.28

5952

56693

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

131

487

2.73

24.81

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

131

487

2.73

24.81

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

131

487

2.73

24.81

1.7

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

268

1361

2.01

24.67

1.6

1.4

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

229

1098

2.13

24.60

1.4

1.3

100.00

200.91

titre

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1242

9303

1.42

24.60

1.4

1.3

11.16

11.10

u/ml

0.01

524

3592

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

628

4093

1.59

24.59

4.9

3.7

5.19

5.14

kpa

0.74

598

3932

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

228

1094

2.12

24.45

1.4

1.3

88.33

371.53

titre

3.19

(3020779) Urea [Moles/volume] in Serum or Plasma

827

5746

1.50

24.25

11.7

7.8

10.81

10.11

mmol/l

1.94

794

5516

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

328

1803

1.86

23.87

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

382

2215

1.77

23.32

2.5

2.3

609.51

615.48

ug/l

0.01

360

2113

(40758558) Short blood count panel - Blood

2105

17267

1.33

23.23

7.8

6.5

—

(3045414) Leukocytes [Presence] in Urine

795

5525

1.50

23.22

2.4

2.1

0.02

0.01

estimate

0.37

166

1173

(3021440) Promyelocytes/Leukocytes in Blood

749

5147

1.52

23.08

6.3

4.5

0.09

0.11

0.56

262

1437

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5522

52007

1.47

23.06

6.1

5.2

6.08

5.99

mmol/l

4.40

5141

47910

(3009343) pH of Capillary blood

606

3975

1.58

23.04

4.8

3.7

7.42

0.22

503

3319

(3025941) Bacteria identified in Stool by Culture

470

2896

1.67

23.03

1.3

1.2

—

(40768804) Tissue Pathology biopsy report

2610

22087

1.31

22.94

2.5

2.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

301

1632

1.89

22.87

1.6

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3719

33016

1.30

22.75

3.2

2.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1084

8045

1.42

22.39

1.8

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

169

748

2.29

22.14

1.7

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5449

51290

1.44

21.84

8.0

6.6

40.48

39.50

mmol/mol

11.15

5178

48141

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

212

1038

2.08

21.59

1.8

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

286

3.11

21.30

2.3

2.4

20.25

22.73

umol/l

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

102

361

2.86

21.25

2.3

2.7

0.63

0.66

e9/l

0.31

347

(3044889) 12 lead EKG panel

4297

39091

1.31

20.88

5.0

4.2

0.47

4905.61

0.68

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5633

53446

1.48

20.76

6.1

5.2

4.47

4.56

mmol/l

10.95

5316

50128

(3020961) Endomysium IgA Ab [Titer] in Serum

412

2521

1.68

20.70

1.2

1.1

141.82

177.73

titre

0.23

(3025159) Blasts/Leukocytes in Blood

742

5204

1.48

20.58

6.8

4.6

0.19

0.24

0.15

249

1373

(3004119) Hemoglobin [Mass/volume] in Venous blood

581

3870

1.55

20.58

4.1

3.4

129.34

129.94

g/l

0.25

560

3757

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5603

53122

1.46

20.57

5.8

5.1

1.42

mmol/l

0.65

5249

49516

(3000475) Leukocytes [#/volume] in Synovial fluid

273

1486

1.87

20.50

1.8

1.6

13500.48

12711.33

e6/l

0.08

214

1027

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

225

1152

1.99

20.28

1.6

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5391

50786

1.41

20.23

5.1

4.4

1.34

1.31

mmol/l

2.66

5020

46885

(3007461) Platelets [#/volume] in Blood

6059

58520

1.76

19.92

37.3

25.4

246.15

246.89

e9/l

0.36

5993

57371

(3024731) MCV [Entitic mean volume] in Red Blood Cells

6060

58534

1.76

19.89

37.1

25.3

91.45

91.18

4.55

6019

57935

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

6060

58537

1.76

19.85

37.9

25.9

41.14

40.87

0.13

6018

57911

(3026361) Erythrocytes [#/volume] in Blood

6060

58538

1.76

19.83

37.2

25.3

4.46

4.51

e12/l

11.74

5972

57209

(3000963) Hemoglobin [Mass/volume] in Blood

6061

58551

1.76

19.82

37.6

25.5

134.56

136.10

g/l

12.57

6021

57965

(3035941) MCH [Entitic mass]

6059

58532

1.76

19.74

37.1

25.3

30.41

30.39

0.30

6018

57934

(3010813) Leukocytes [#/volume] in Blood

6060

58547

1.76

19.70

37.3

25.4

6.93

6.77

e9/l

5.16

5974

57214

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1489

11844

1.34

19.67

1.8

1.7

55694665.31

29412782.54

pmol/l

0.74

1282

9921

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

559

3731

1.55

19.59

5.5

4.1

24.11

24.17

mmol/l

0.17

553

3692

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

152

3.84

19.58

2.1

1.5

9.18

8.95

ug/l

0.14

152

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

146

641

2.31

19.54

1.3

1.2

—

(44790047) Parainfluenza type 1 nucleic acid detection

165

763

2.19

19.49

1.8

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

165

763

2.19

19.49

1.8

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

165

763

2.19

19.49

1.8

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

165

763

2.19

19.49

1.8

1.4

—

(3021589) Normoblasts [#/volume] in Blood

2898

25223

1.27

19.25

15.7

11.8

0.00

e9/l

0.17

2459

20512

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5690

54236

1.47

19.02

6.7

5.9

2.57

2.67

mmol/l

14.73

5355

50674

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2294

19430

1.28

18.87

4.1

3.4

32.38

35.81

u/l

1.72

2174

18348

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

524

3484

1.55

18.67

4.7

3.6

1.85

1.77

mmol/l

0.18

393

2561

(3010144) Erythrocytes [#/volume] in Synovial fluid

128

542

2.39

18.62

1.4

234511.60

113556.09

e6/l

0.67

369

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

138

605

2.31

18.55

1.8

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

131

565

2.35

18.29

1.8

1.7

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

330

2.78

18.18

2.9

2.7

38.22

39.91

0.39

178

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

237

1288

1.87

17.92

1.3

3.54

4.30

u/ml

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1324

10477

1.33

17.88

3.6

3.1

1.27

1.07

e6/l

0.50

857

5593

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

236

1282

1.87

17.87

1.8

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1724

14164

1.30

17.72

3.0

2.5

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

623

4346

1.48

17.65

1.6

1.4

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

298

1747

1.74

17.53

1.6

1.4

263.24

270.50

ug/g

0.23

183

1032

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

271

1556

1.77

17.14

1.4

1.3

3.23

6.77

u/ml

1.89

237

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1194

9362

1.34

17.07

2.4

2.2

29.86

29.78

0.16

1161

9122

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

282

1641

1.75

17.03

1.4

1.3

66.78

35.91

u/ml

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

268

1552

1.76

16.47

1.4

1.3

3.34

4.95

u/ml

0.24

147

(3003329) Lymphocytes/Leukocytes in Synovial fluid

119

516

2.33

16.45

1.7

1.5

29.27

30.52

0.14

324

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

168

3.41

16.25

3.0

3.2

111.82

131.54

au/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

249

1417

1.79

16.24

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

605

4268

1.46

16.14

1.6

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

207

1115

1.89

16.12

1.4

1.3

268.58

268.05

u/ml

0.01

124

679

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

215

1174

1.86

16.05

1.5

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

553

3852

1.48

15.74

2.5

2.4

26.52

20.73

au/ml

1.02

388

(3042733) HLA Ab [Presence] in Serum

182

3.26

15.67

5.5

4.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

248

1427

1.77

15.59

1.3

1.2

—

(3011412) CD3 cells [#/volume] in Blood

118

525

2.27

15.39

2.3

2.7

1116.29

1186.10

e6/l

0.47

107

465

(42529406) Shigella sp [Presence] in Stool by Culture

248

1435

1.76

15.30

1.4

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

196

1056

1.88

15.27

1.8

1.5

129.86

151.73

au/ml

1.77

304

(3028626) Oxygen [Partial pressure] in Capillary blood

269

1595

1.72

15.22

4.4

3.3

8.19

8.18

kpa

0.04

263

1560

(3014148) Varicella zoster virus Ab [Titer] in Serum

144

702

2.08

14.95

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

188

3.16

14.88

3.3

4.1

6.95

8.44

mg/l

1.00

155

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

242

1402

1.75

14.87

1.9

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

304

1876

1.65

14.81

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

435

2920

1.53

14.80

1.9

1.7

1.58

1.54

g/l

0.36

374

2531

(3006571) Granulocytes/Leukocytes in Synovial fluid

139

672

2.09

14.76

1.7

1.6

58.51

59.12

0.06

437

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

195

3.10

14.64

2.7

2.0

59.64

60.93

ug/l

0.04

190

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

510

3548

1.48

14.59

1.3

55.69

57.17

au/ml

0.05

251

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4079

37549

1.24

14.50

4.0

3.4

55.51

50.61

u/l

2.03

3846

35329

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.94

14.49

2.1

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

537

3780

1.46

14.46

8.5

10.2

24.35

24.22

mmol/l

0.41

528

3712

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

408

2.40

14.41

2.3

2.4

—

(3044640) Blood type and Crossmatch panel - Blood

2152

18520

1.24

14.37

3.0

2.6

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

106

465

2.30

14.32

1.9

1.5

—

(3035933) Granulocytes/Leukocytes in Blood

219

1248

1.78

14.26

3.9

3.3

57.85

58.14

0.12

219

1248

(3021901) Oxygen saturation in Capillary blood

224

1299

1.75

13.75

4.1

3.1

89.85

89.67

0.13

217

1267

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

208

1185

1.78

13.57

1.8

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

191

3.00

13.24

1.7

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

219

1278

1.74

13.16

1.6

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

278

1729

1.64

13.16

2.0

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

253

1547

1.66

12.81

2.1

2.0

12.32

11.68

mg/l

0.53

236

1440

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

292

2.55

12.65

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

269

1682

1.63

12.47

1.4

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

321

2095

1.56

12.43

3.6

3.3

0.34

iu/ml

0.05

189

1155

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

172

953

1.83

12.34

1.5

1.4

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

5436

52055

1.31

12.22

21.9

16.5

79.58

80.55

ml/min/173m2

2.71

5153

48296

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

369

2493

1.51

12.19

2.1

1.9

39.63

39.39

u/l

0.07

327

2217

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

510

3672

1.42

12.14

9.7

10.6

16.20

16.04

0.66

493

3549

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1118

9069

1.28

12.02

1.6

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

122

608

2.03

12.02

1.4

0.49

0.40

g/l

1.41

444

(3028192) IgG subclass 2 [Mass/volume] in Serum

122

608

2.03

12.02

1.4

3.07

2.99

g/l

0.16

444

(3004616) Nuclear Ab [Presence] in Serum

134

691

1.96

11.99

1.3

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

122

609

2.02

11.96

1.4

6.65

6.93

g/l

0.39

445

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

317

2086

1.55

11.84

2.0

1.8

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

285

1832

1.58

11.80

4.9

3.6

1.71

1.56

mg/l

1.85

261

1686

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4792

45251

1.24

11.79

32.1

21.3

332.12

332.73

g/l

4.69

4771

44998

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

114

559

2.06

11.74

2.1

1.6

479.95

347.96

mu/l

0.72

442

(4062490) Immunoglobulin typing, IgG

119

599

2.01

11.42

1.5

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

354

2411

1.50

11.27

1.5

1.4

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4761

44999

1.23

11.23

27.3

20.6

13.85

13.65

19.90

4715

44416

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

313

2084

1.53

11.10

3.4

3.5

39.81

55.06

mg/l

1.09

264

1775

(3023419) Bacteria identified in Sputum by Culture

142

767

1.87

11.09

2.9

2.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

138

739

1.89

11.07

1.5

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

313

2086

1.53

11.05

3.4

3.5

52.43

80.49

mg/l

0.52

266

1775

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

116

586

2.00

11.04

2.4

36.86

28.07

iu/ml

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

175

1009

1.76

11.03

1.6

0.69

0.84

g/l

1.18

135

798

(3013512) EKG study

2239

19742

1.21

11.00

4.1

3.7

0.82

0.74

0.24

(3048929) Epstein Barr virus Ab [Presence] in Serum

270

1746

1.57

10.92

1.4

1.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

157

880

1.80

10.90

7.1

6.6

11.74

11.88

mg/l

0.14

151

819

(3037756) Immunofixation for Serum or Plasma

210

1281

1.66

10.78

1.6

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

459

3317

1.41

10.70

3.5

3.4

4.42

4.49

pmol/l

0.60

405

2973

(3045424) Erythrocytes [Presence] in Urine

404

2854

1.44

10.68

2.5

2.2

0.00

0.29

estimate

0.54

135

899

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

258

1666

1.57

10.51

1.5

1.4

12.71

15.62

iu/ml

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

347

2.26

10.32

1.3

1.2

—

(3022313) Gas panel - Capillary blood

395

2797

1.44

10.31

4.9

3.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

220

1375

1.62

10.28

2.5

2.7

31.78

34.18

umol/l

0.65

192

1252

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

197

1198

1.67

10.26

1.4

1.2

56.50

42.22

u/ml

0.61

118

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

221

1387

1.61

10.16

2.5

2.3

216.63

114.08

ug/min

1.12

132

851

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

331

2276

1.48

10.07

2.2

2.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

270

2.42

10.05

1.2

1.1

4.67

3.73

iu/ml

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

133

728

1.84

10.00

1.5

1.4

—

(3004809) Band form neutrophils/Leukocytes in Blood

170

1003

1.71

9.92

4.8

3.6

1.25

1.68

1.04

152

901

(3003129) Base excess in Capillary blood by calculation

130

710

1.85

9.85

2.5

2.3

0.31

0.44

mmol/l

0.14

122

683

(3024522) Salmonella sp identified in Specimen by Organism specific culture

133

732

1.83

9.84

1.5

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

361

2.20

9.82

2.4

2.9

498.97

529.98

e6/l

0.22

294

(3013166) Neutrophils/Leukocytes in Synovial fluid

168

2.81

9.82

1.6

1.3

60.59

54.30

0.55

142

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

4.90

9.77

1.8

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

343

2.23

9.74

1.3

1.2

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

339

2369

1.46

9.51

2.8

2.3

2.82

2.91

g/l

0.86

313

2158

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

243

2.44

9.32

5.1

3.1

1.37

1.33

0.08

243

(3019832) Treponema pallidum Ab [Presence] in Serum

574

4397

1.34

9.32

1.9

1.8

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

112

595

1.90

9.28

4.8

4.0

—

(3022145) Colonoscopy Study observation

824

6633

1.28

9.26

1.5

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

146

2.89

9.25

1.7

1.4

—

(3024471) HLA-A [Type]

169

2.73

9.16

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

4.27

9.10

1.0

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

388

2803

1.41

9.08

5.1

5.2

1.73

1.63

0.70

368

2655

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

266

1789

1.51

9.05

2.7

2.8

3.53

3.57

g/l

0.17

250

1711

(3024932) HLA-DR beta [Type]

165

2.74

9.00

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

133

760

1.77

8.74

1.7

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2531

22895

1.18

8.68

5.3

5.5

2.84

2.99

ug/l

0.13

2305

20820

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

856

6976

1.26

8.67

2.0

1.8

1.56

1.50

1.69

739

6101

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

180

2.62

8.65

2.0

2.1

7.98

9.21

mg/l

1.02

152

(3009466) Valproate [Moles/volume] in Serum or Plasma

143

838

1.72

8.61

4.8

5.4

348.68

356.27

umol/l

0.23

129

734

(3025468) Yersinia sp identified in Specimen by Organism specific culture

123

694

1.79

8.45

1.5

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

200

2.51

8.44

1.3

1.2

—

(3045716) Anion gap in Serum or Plasma by calculation

121

680

1.79

8.42

3.3

3.2

10.12

10.63

mmol/l

0.71

121

670

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

178

2.60

8.31

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

273

1880

1.47

8.30

3.4

3.3

3.60

2.82

ratio

0.16

153

1087

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

606

4760

1.30

8.22

3.5

3.0

194.87

202.01

ng/l

0.18

560

4347

(3005988) Vibrio sp identified in Specimen by Organism specific culture

123

700

1.77

8.22

1.5

1.4

—

(21494755) Public health laboratory ask at order entry panel

354

4812

0.72

8.15

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

122

698

1.76

8.02

1.5

1.4

—

(40757373) Influenza virus identified in Isolate

109

3.04

7.98

1.8

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1803

15942

1.18

7.98

4.3

3.3

1.25

0.10

estimate

1.01

625

4887

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

115

648

1.79

7.96

1.3

1.49

1.52

nmol/l

0.09

105

582

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

729

5890

1.27

7.91

4.1

3.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2053

18362

1.17

7.89

4.7

4.5

22.53

22.08

0.66

995

9087

(3010838) Calcium [Moles/time] in 24 hour Urine

157

967

1.64

7.87

2.2

1.9

5.39

4.92

mmol/24h

0.87

138

851

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

347

2526

1.40

7.81

2.7

2.3

4.19

4.21

g/l

0.23

322

2314

(3013139) Helicobacter pylori Ag [Presence] in Stool

487

3739

1.33

7.79

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

347

2527

1.39

7.79

2.7

2.3

7.39

7.38

g/l

0.03

321

2313

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

4.05

7.79

1.9

2.15

1.50

mg/l

0.78

(21494890) Protein electrophoresis panel - 24 hour Urine

111

624

1.79

7.76

2.4

2.1

—

(40768446) Kidney Pathology biopsy report

221

2.36

7.74

2.4

1.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

346

2524

1.39

7.69

2.7

2.3

3.60

3.74

g/l

1.41

320

2312

(3042111) Morphology [Interpretation] in Bone marrow Narrative

167

1051

1.60

7.69

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

420

1.96

7.64

1.2

85.00

82.03

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

387

2.00

7.57

1.4

1.3

0.49

1.71

u/ml

1.52

220

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

150

923

1.64

7.57

1.2

1.3

—

(40768797) Stomach Pathology biopsy report

939

7851

1.23

7.50

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

201

1329

1.53

7.47

1.7

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

158

992

1.61

7.36

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

4.01

7.33

1.1

0.05

0.02

u/ml

1.23

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

216

1457

1.50

7.32

2.6

2.3

1475.58

5875.66

u/l

3.88

570

(3026782) Osmolality of Urine

1315

11389

1.19

7.29

3.8

3.0

516.22

541.56

mosm/kgh2o

4.46

1198

10032

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

325

2.07

7.27

1.3

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

366

2.01

7.24

2.5

3.0

233.00

223.22

e6/l

0.16

314

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

532

4179

1.30

7.22

8.9

8.6

24.86

24.82

mmol/l

0.11

527

4159

(3017354) Segmented neutrophils/Leukocytes in Blood

112

650

1.74

7.06

4.5

3.7

59.16

57.21

0.54

565

(36660697) Celiac disease serology panel - Serum

558

4437

1.28

6.89

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

301

2188

1.39

6.87

2.7

2.3

0.60

0.91

g/l

0.92

263

1870

(1616796) Gas panel - Central venous blood

202

1364

1.50

6.84

5.3

4.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

336

2.00

6.68

1.6

5.92

7.19

u/l

0.30

273

(3000093) Morphology [Interpretation] in Blood Narrative

104

601

1.74

6.68

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

280

2026

1.40

6.58

4.5

3.3

1518.49

368.97

mg/l

0.91

147

937

(3047181) Lactate [Moles/volume] in Blood

257

1832

1.42

6.57

6.1

6.2

1.44

1.29

mmol/l

0.78

226

1622

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

286

2.07

6.46

1.2

1.1

1650.85

1515.73

miu/ml

0.39

286

(3040151) Glucose [Moles/volume] in Capillary blood

113

677

1.68

6.39

5.4

15.5

7.73

7.33

mmol/l

0.45

579

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

361

2734

1.34

6.38

1.1

2.27

0.93

u/ml

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

142

2.54

6.34

1.4

1.3

35.35

32.75

0.14

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

299

2203

1.37

6.31

5.0

3.8

24.72

24.77

mmol/l

0.13

275

2032

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

818

6867

1.22

6.24

3.4

2.8

9.27

8.89

umol/l

0.17

708

6077

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

101

593

1.71

6.16

1.1

—

4.17

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

127

2.61

6.11

1.8

1.6

102.44

123.85

au/ml

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

341

2579

1.34

6.10

5.5

5.4

0.83

0.87

0.99

323

2443

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

350

1.92

5.99

1.5

5.80

6.57

u/l

0.48

301

(3003181) Sodium [Moles/volume] in Urine

167

1117

1.51

5.97

1.3

1.4

62.01

61.55

mmol/l

0.05

133

909

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

586

1.70

5.88

1.2

70.52

63.50

u/l

0.33

513

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

465

5811

0.78

5.87

1.9

2.0

3.46

3.55

ratio

0.84

369

4525

(3011985) Renin [Units/volume] in Plasma

131

836

1.58

5.79

1.6

1.4

49.37

65.72

mu/l

0.64

118

748

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2542

23484

1.14

5.75

2.2

1.9

1.41

1.37

mmol/l

1.49

2185

19833

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

564

4596

1.25

5.69

4.6

4.1

1.22

1.23

mmol/l

0.67

502

4015

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

373

2888

1.31

5.68

2.4

—

(3019225) pH of Specimen

654

5420

1.23

5.65

5.6

4.5

7.36

7.35

0.04

496

3927

(3034891) Synovial lining cells/cells in Synovial fluid

267

2.03

5.65

1.6

1.4

2.31

4.27

0.57

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

211

1496

1.42

5.62

1.4

500.22

555.49

mg/l

0.81

202

1422

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1311

11578

1.17

5.60

5.0

4.0

362.16

524.63

ng/l

0.86

1043

9251

(40765096) Chromosome analysis panel by Banding

197

2.19

5.48

1.3

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

515

1.72

5.48

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

243

1775

1.38

5.46

2.8

2.2

0.00

g/l

0.50

213

1552

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

191

2.21

5.45

1.2

1.3

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

3.23

5.44

1.1

1.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

289

2174

1.35

5.39

2.6

2.3

10.05

10.23

g/l

0.27

261

1943

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

272

1.99

5.39

2.2

1.7

189.48

124.09

umol/l

0.66

141

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

212

2.13

5.36

2.5

2.7

0.61

mmol/l

0.15

212

(3008295) Osmolality of Serum or Plasma

107

666

1.62

5.29

1.5

1.4

279.86

278.70

mosm/kgh2o

0.18

508

(3006184) Hemoglobin [Mass/volume] in Capillary blood

207

1480

1.41

5.28

3.3

2.3

129.09

130.22

g/l

0.26

158

1143

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

188

1321

1.44

5.28

1.3

3.76

3.80

mmol/l

0.25

175

1248

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

181

2.22

5.27

1.4

1.5

14.83

16.13

pmol/l

0.59

151

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

775

6579

1.20

5.26

1.6

1.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

6.68

5.24

4.7

5.0

—

(3042631) Mycobacterium sp identified in Specimen

125

809

1.56

5.24

2.5

2.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

166

1142

1.47

5.22

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

166

1142

1.47

5.22

1.4

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

710

5982

1.21

5.21

2.4

2.3

13.70

13.38

nmol/l

0.46

656

5406

(3034274) Bile acid [Moles/volume] in Serum --fasting

523

1.69

5.20

1.9

10.67

8.00

umol/l

0.24

370

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

295

2239

1.33

5.20

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

290

1.94

5.18

1.8

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

290

1.94

5.18

1.8

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

290

1.94

5.18

1.8

1.9

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

291

1.93

5.14

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

243

1794

1.37

5.13

1.4

1.3

—

(44813793) Dust mix specific IgE antibody measurement

355

1.84

5.13

1.0

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

460

3716

1.26

5.03

2.0

1.7

—

(4034850) Laboratory test

230

1690

1.37

5.01

13.4

10.2

—

(3039000) Anion gap in Blood by calculation

179

1265

1.43

4.90

7.0

7.3

11.61

11.32

mmol/l

0.39

161

1139

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

479

1.70

4.90

1.4

1.3

2.75

2.12

mmol/l

0.70

448

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

2.67

4.90

1.1

1.8

1.48

1.98

ug/l

0.73

(3008898) HLA-B27 [Presence]

239

1774

1.36

4.90

1.1

—

(3018572) Chloride [Moles/volume] in Blood

179

1266

1.43

4.88

7.0

7.3

105.19

105.07

mmol/l

0.14

161

1140

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

189

1350

1.41

4.88

1.1

2.67

7.67

eliau/ml

2.28

163

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

248

1854

1.35

4.86

2.8

2.2

0.01

0.03

g/l

1.88

228

1663

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

290

1.90

4.85

1.8

1.9

—

(21494814) CD8 cells/Lymphocytes in Specimen

228

2.02

4.84

1.9

2.2

29.15

31.30

0.44

228

(3028433) Virus identified in Specimen by Culture

169

2.20

4.79

1.2

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

224

1652

1.37

4.79

2.9

2.2

0.00

g/l

-0.00

212

1550

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.88

4.75

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

218

1606

1.37

4.70

1.6

1.5

9.27

8.99

u/l

0.13

180

1278

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

214

1573

1.37

4.68

1.4

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

231

2.00

4.68

2.4

413.19

153.98

ug/l

0.28

213

(3003434) Protein [Mass/volume] in Pleural fluid

134

906

1.49

4.64

1.5

31.59

32.68

g/l

0.44

120

821

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

232

1.99

4.63

1.4

1.3

3.76

4.58

umol/l

0.86

203

(3000060) B lymphocytes [#/volume] in Blood

146

2.27

4.62

2.9

2.8

0.16

0.18

e9/l

0.11

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

130

876

1.49

4.58

1.2

1.3

1.91

3.85

u/ml

2.32

308

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

243

1831

1.34

4.54

2.5

92.29

91.73

0.14

235

1776

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

468

1.67

4.51

1.4

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

1746

15941

1.13

4.50

3.4

2.9

0.14

0.07

0.39

386

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

258

1.91

4.38

1.9

1.6

28.31

28.91

umol/l

0.17

240

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

150

2.21

4.35

1.4

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

118

789

1.50

4.34

1.5

1742.77

3304.93

e6/l

0.69

561

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

119

2.36

4.31

1.1

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

113

2.40

4.30

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

560

1.60

4.28

3.3

3.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

345

2749

1.27

4.28

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

240

1.92

4.23

1.0

1.1

106.13

327.12

ng/l

1.02

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

340

2711

1.27

4.20

2.3

2.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

126

860

1.47

4.20

1.2

1.3

5.69

4.28

u/ml

0.21

388

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

341

4241

0.79

4.18

1.6

1.7

3.36

3.47

mmol/l

0.95

241

2948

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

160

2.13

4.14

1.1

95.14

86.36

1.33

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

103

2.43

4.12

1.1

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

144

1013

1.43

4.11

1.1

—

(3002256) Pathology report gross observation

870

7617

1.16

4.10

1.4

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

208

1.98

4.10

2.0

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

104

688

1.52

4.05

2.5

2.0

26.16

23.55

mg/l

0.24

253

(3034770) Mitochondria Ab [Titer] in Serum

220

1665

1.33

4.03

1.2

1667.27

881.59

titre

0.66

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

420

3449

1.23

4.02

1.2

123.61

131.56

u/ml

0.18

171

1254

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

172

1254

1.38

4.01

2.4

2.0

0.84

0.86

nmol/l

0.12

149

1061

(3002619) Bacteria identified in Specimen by Culture

136

2.21

4.01

1.6

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

130

902

1.45

4.00

1.2

1.1

20.98

17.42

au/ml

0.19

218

(3006922) Hepatitis E virus Ab [Presence] in Serum

462

1.63

3.96

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.60

3.96

1.5

1.4

49.78

56.61

ng/l

0.08

(3036782) Glucose [Moles/volume] in Pleural fluid

645

1.53

3.92

1.4

6.49

6.31

mmol/l

0.22

606

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

112

2.33

3.91

1.2

1.3

98.64

75.47

1.20

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.57

3.87

1.0

1.1

5.18

3.65

u/ml

0.13

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.29

3.81

1.0

1.3

0.83

0.84

iu/ml

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

159

2.08

3.81

1.2

1.3

103.67

83.71

3.35

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

309

1.75

3.76

1.1

1.2

1.08

1.07

ratio

0.18

254

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

208

1.93

3.76

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

208

1.93

3.76

2.0

2.1

—

(3045788) Cell count panel - Pleural fluid

637

1.51

3.71

1.5

1.4

—

(4024509) Urine culture

321

2583

1.26

3.71

1.9

2.0

—

(3014271) Vancomycin [Susceptibility]

267

1.80

3.68

3.6

2.9

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

219

1683

1.31

3.64

3.2

2.8

209.45

196.22

1.08

209

1607

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

373

1.67

3.62

1.3

1.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

548

4668

1.19

3.62

2.3

2.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

137

980

1.41

3.61

1.1

1.2

1.11

0.76

—

(4195642) Thrombophilia screening test

115

797

1.45

3.60

1.1

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

219

1686

1.31

3.60

1.2

105.24

137.68

titre

0.36

142

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

199

1512

1.33

3.59

1.3

154.32

210.49

miu/ml

1.38

656

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

189

1426

1.34

3.58

1.2

1.1

4.79

4.03

0.33

184

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.77

3.55

2.4

3.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

314

2535

1.25

3.54

1.8

1.7

0.32

mg/l

0.05

161

1214

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

220

1.87

3.53

1.8

1.9

475.00

19790.47

u/ml

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

316

1.71

3.50

1.1

24.98

27.25

u/l

0.13

286

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

624

1.50

3.44

1.5

1.4

22.07

25.75

u/l

0.61

519

(3033099) Centromere Ab [Titer] in Serum

119

2.19

3.43

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

180

1.95

3.42

1.1

1.2

—

(3036489) Thrombin time

276

2205

1.26

3.42

2.4

2.3

20.65

21.17

1.00

244

1967

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

252

1.79

3.40

2.9

1.9

162.32

162.02

0.01

241

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

365

1.65

3.38

1.3

1.4

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

112

783

1.44

3.38

1.4

1.3

1201.30

303.23

pmol/l

0.49

660

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

196

1.89

3.33

3.1

2.9

9.67

10.42

kpa

0.78

196

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

196

1.89

3.33

3.1

2.9

5.04

4.84

kpa

0.38

196

(3028308) Erythrocytes [#/volume] in Pleural fluid

101

696

1.46

3.29

1.5

1.4

74726.16

62279.37

e6/l

0.14

398

(40759836) Histone Ab [Presence] in Serum by Immunoblot

446

1.58

3.29

1.2

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

219

1710

1.29

3.27

1.9

189.78

208.54

pmol/l

2.14

210

1615

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

301

1.70

3.23

1.1

1.08

1.12

u/l

0.19

138

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

625

1.48

3.23

1.4

362.34

355.12

u/l

0.04

600

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

172

1302

1.33

3.23

1.5

25.79

26.01

e6/l

0.00

134

950

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

318

1.67

3.17

1.1

81.42

87.41

u/l

0.18

287

(3017704) Immunofixation for Urine

319

1.67

3.14

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

147

1957

0.75

3.12

1.1

1.2

1.48

1.51

g/l

0.77

147

1957

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

444

1.56

3.12

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

460

1.55

3.12

1.2

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

358

1.63

3.12

2.0

7.61

8.11

mmol/l

0.52

358

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

177

1355

1.32

3.09

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.80

3.08

2.2

1.5

50.57

46.18

umol/l

0.24

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.33

3.07

1.9

2.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

112

2.15

3.05

1.1

1.3

89.56

73.55

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

276

1.71

3.05

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

173

1323

1.32

3.04

1.5

1000.07

1149.34

e6/l

0.08

142

1038

(3024263) Appearance of Synovial fluid

299

1.68

3.04

1.6

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

577

1.48

3.02

1.7

1.5

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

277

1.70

3.02

1.2

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.55

2.98

1.1

1.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

355

1.61

2.97

1.9

2.0

104.92

115.99

ng/l

0.41

355

(1761868) Lipid panel - Serum or Plasma

1983

21120

0.91

2.96

3.3

3.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

115

833

1.39

2.89

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

156

1.93

2.89

2.3

3.3

1.59

2.11

ratio

1.02

142

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

115

2.09

2.87

1.8

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

305

1.64

2.84

3.9

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

157

1.92

2.84

1.2

—

(3018333) Ribosomal P Ab [Presence] in Serum

415

1.55

2.84

1.3

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

110

794

1.39

2.83

1.1

1.2

118.58

114.54

0.66

102

725

(3035880) pH of Pleural fluid

352

1.60

2.83

1.3

7.43

7.39

0.78

246

(3009871) Measles virus Ab [Titer] in Serum

215

1.77

2.83

1.4

1.7

3154.29

3167.18

titre

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

432

1.53

2.81

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

253

1.70

2.80

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

253

1.70

2.80

1.4

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

139

1831

0.75

2.78

1.0

1.1

0.68

0.64

ratio

0.23

245

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

425

1.53

2.78

1.3

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.08

2.76

1.0

1.2

1.99

1.25

iu/ml

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

112

815

1.38

2.76

2.1

2.2

32.67

32.62

0.04

112

810

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

442

1.52

2.76

1.3

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.34

2.75

3.8

6.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

210

1.77

2.73

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

443

1.52

2.73

1.3

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

708

1.40

2.71

1.5

1.4

0.25

0.33

nmol/l

1.61

539

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

114

835

1.37

2.71

1.1

1.57

1.52

g/l

0.64

107

762

(3000285) Sodium [Moles/volume] in Blood

118

2.04

2.71

1.2

139.38

138.92

mmol/l

0.31

(3020191) Ethanol [Moles/volume] in Serum or Plasma

509

1.48

2.71

1.9

1.3

1.12

1.24

promille

0.29

406

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

396

1.55

2.71

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

149

1137

1.32

2.70

1.2

1.3

28.69

36.67

u/l

0.71

132

987

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

493

1.49

2.70

1.4

1.3

12.44

13.16

u/l

0.18

454

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.24

2.70

10.2

12.4

5.62

5.77

mmol/l

0.05

(3017569) Oxygen content in Arterial blood

373

1.56

2.68

2.3

2.2

16.22

16.34

0.11

373

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

272

1.66

2.67

2.2

2.4

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

430

1.52

2.65

1.1

259.81

286.53

mg/l

0.63

373

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

182

1436

1.28

2.58

2.3

2.0

77.56

7.61

iu/l

0.47

598

(3027456) Digoxin [Moles/volume] in Serum or Plasma

150

1154

1.31

2.58

3.9

3.2

0.82

0.81

nmol/l

0.11

124

918

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

3.06

2.56

1.2

1.6

16.12

21.68

pmol/l

—

(3020876) Protein [Mass/time] in 24 hour Urine

105

767

1.38

2.56

3.2

2.4

1.23

1.34

g/24h

0.15

466

(3042517) Benzodiazepines panel - Urine

2.86

2.54

2.7

2.9

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

108

2.04

2.51

1.5

1.2

2.25

2.09

mmol/l

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

332

1.57

2.50

1.3

1.2

37.64

23.98

u/l

0.44

269

(3044927) Protein electrophoresis panel - Urine

568

1.43

2.50

1.4

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

172

1.81

2.49

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

172

1.81

2.49

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

172

1.81

2.49

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

172

1.81

2.49

1.3

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

113

840

1.35

2.48

1.5

1.3

0.28

nmol/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

152

1.85

2.42

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

234

1.67

2.41

2.5

1.7

39.72

40.02

g/l

0.12

234

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

539

1.43

2.41

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

103

2.04

2.41

1.3

1.9

900.00

7852.14

u/ml

—

(21494434) Karyotype in Bone marrow

556

1.43

2.40

1.1

1.2

—

(3012441) Differential panel - Pleural fluid

683

1.38

2.39

1.4

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

197

1.73

2.38

3.6

2.8

31.32

28.84

umol/l

0.85

139

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.21

2.37

1.1

—

(40761536) Microorganisms panel - Urine sediment

508

4461

1.15

2.37

5.6

4.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

625

1.40

2.36

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

314

1.56

2.34

1.8

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

314

1.56

2.34

1.8

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

370

1.52

2.34

1.4

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

181

1447

1.26

2.34

1.5

1.4

—

(3020393) Adenovirus Ag [Presence] in Stool

2.38

2.29

1.1

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

357

1.52

2.26

1.4

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

213

1742

1.23

2.26

1.7

303.13

294.01

mu/l

0.14

199

1593

(4015189) Microbial culture of sputum

127

1.89

2.25

1.4

1.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

156

1.80

2.25

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

708

1.36

2.24

1.5

1.3

0.19

0.21

nmol/l

0.32

569

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.28

2.24

1.7

3.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

407

1.48

2.23

1.1

1.0

—

0.62

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

701

1.36

2.22

1.5

1.3

—

nmol/l

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

5.56

2.21

1.0

1.1

1.36

1.37

mg/l

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

150

1.80

2.19

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

265

1.59

2.16

1.3

156.19

172.79

mmol/24h

0.49

265

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

122

1.89

2.15

1.0

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

267

1.58

2.11

2.3

5.4

58.10

65.91

mg/l

0.55

190

(3032057) Clostridioides difficile [Presence] in Stool

109

1.93

2.10

2.0

1.9

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

138

1.81

2.08

1.3

1.6

0.42

0.38

ug/l

0.19

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

447

1.44

2.07

1.2

1.1

35.47

43.24

mg/l

1.41

369

(4268621) Lupus anticoagulant assay

624

1.37

2.07

2.2

2.3

—

(37208534) Antinuclear antibody arbitrary concentration in serum

168

1.73

2.07

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

156

1247

1.26

2.06

5.9

4.4

8.51

8.58

kpa

0.21

151

1227

(3036670) Protein [Mass/volume] in Synovial fluid

176

1.71

2.05

1.4

1.2

38.13

40.10

g/l

0.24

(3013290) Carbon dioxide [Partial pressure] in Blood

155

1239

1.26

2.05

5.8

4.4

5.08

5.01

kpa

0.55

150

1220

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

139

1.80

2.04

1.1

—

(3033086) Enterovirus Ab [Titer] in Serum

4.00

2.04

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.00

2.04

3.2

2.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

569

5092

1.13

2.03

2.4

2.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

111

852

1.31

2.02

3.3

2.7

59.07

384.31

u/ml

0.54

111

840

(3033658) Prothrombin time (PT) actual/Normal

1584

14915

1.08

2.02

5.4

4.4

87.55

87.86

0.19

1546

14616

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

162

1.73

2.01

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

3.08

2.01

1.6

1.4

14.34

2.63

u/ml

—

(3004451) EKG impression Narrative

343

1.49

2.01

1.4

1.2

—

(3042951) Complement C1q Ab [Units/volume] in Serum

3.34

1.96

1.0

1.1

—

23.61

—

(3012501) Base excess in Blood by calculation

154

1239

1.25

1.94

5.8

4.4

2.45

2.56

mmol/l

0.24

112

840

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.19

1.94

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

123

965

1.28

1.92

1.1

71.76

865.07

iu/ml

0.67

202

(3035320) C reactive protein [Mass/volume] in Body fluid

448

1.41

1.88

2.5

2.7

26.79

30.58

mg/l

0.33

319

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

181

1.66

1.87

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.16

1.87

1.3

1.2

8.36

5.44

mmol/l

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

499

1.39

1.87

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

241

2038

1.19

1.87

1.6

18.88

16.78

u/ml

0.21

467

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

300

1.50

1.86

1.3

1.2

—

(3045142) Bone marrow Pathology biopsy report

715

1.32

1.85

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

401

1.43

1.81

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.12

1.81

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

393

1.43

1.81

1.4

1.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

327

1.47

1.80

1.2

0.52

0.57

ratio

0.97

190

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.06

1.80

1.9

1.7

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.05

1.80

1.6

1.4

516.96

483.64

nmol/l

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.00

1.79

1.1

—

(3022475) Manganese [Moles/volume] in Blood

2.76

1.79

1.6

1.4

0.19

0.17

umol/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.34

1.77

2.0

2.6

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.17

1.77

1.2

1.1

0.01

0.16

u/ml

—

(4035726) Immunohistochemistry procedure

556

5020

1.12

1.74

1.6

1.4

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

147

1.70

1.73

1.4

27.39

22.12

0.35

121

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1039

9676

1.09

1.73

3.9

3.2

2.16

2.15

e6/l

0.01

574

4771

(3025549) Creatine [Moles/time] in 24 hour Urine

2.44

1.64

1.2

1.5

—

(3000012) Reticulocyte production index

114

907

1.26

1.63

2.0

2.2

0.91

0.90

0.05

616

(3027923) C peptide [Moles/volume] in Serum or Plasma

343

1.43

1.63

1.3

1.4

1.19

1.22

nmol/l

0.06

248

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

165

1368

1.21

1.62

1.3

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.00

1.58

1.0

1.1

0.05

u/ml

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.69

1.58

1.0

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

173

1446

1.20

1.57

1.2

1.1

—

(3024928) Oxygen saturation in Venous blood

193

1630

1.19

1.57

3.9

3.3

65.08

61.47

1.59

183

1585

(3026470) Cobalt [Mass/volume] in Blood

363

1.41

1.56

2.3

2.2

3.43

3.25

ug/l

0.06

331

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

313

1.44

1.56

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

305

1.45

1.55

1.0

—

(44806071) Cardiolipin IgM antibody measurement

1.97

1.53

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

100

1.80

1.52

2.9

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

121

980

1.24

1.51

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

108

1.76

1.50

1.2

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

189

1601

1.19

1.50

3.7

3.4

1.78

2.07

index

0.35

102

843

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

619

5674

1.10

1.48

2.9

2.6

34.60

47.71

u/l

0.87

536

4842

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

101

1.78

1.48

1.4

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.00

1.48

1.1

—

(3025577) Chromium [Mass/volume] in Blood

352

1.40

1.45

2.2

2.04

2.13

ug/l

0.08

295

(3011897) Casein IgE Ab [Units/volume] in Serum

1.88

1.44

1.3

1.2

59.11

0.85

u/ml

0.76

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.31

1.43

1.3

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.31

1.43

1.3

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

1.79

1.42

1.1

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

205

2382

0.86

1.41

1.5

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

103

1.75

1.40

1.4

2.0

—

(40768800) Prostate Pathology biopsy report

121

1472

0.82

1.40

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

263

1.45

1.38

1.9

1.6

1.04

3.48

u/field

2.12

188

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

119

1.68

1.37

1.1

1.2

—

11.20

—

(3013727) Leukocytes other/Leukocytes in Blood

174

1.55

1.36

6.0

3.1

52.31

53.26

0.08

168

(40768441) Liver Pathology biopsy report

435

1.34

1.4

—

(40768806) Pleura Pathology biopsy report

681

1.27

1.33

1.4

1.6

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

576

1.29

1.32

1.3

1.2

—

34.11

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

658

6087

1.09

1.32

3.6

4.5

16.96

24.75

ug/l

0.70

537

5030

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

168

1.55

1.31

1.0

1.2

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

0.00

1.31

0.0

1.8

—

17.65

—

(3008037) Lactate [Moles/volume] in Venous blood

173

1476

1.18

1.30

3.1

1.50

1.64

mmol/l

1.31

166

1430

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.35

1.29

1.0

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.78

1.28

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

413

1.33

1.27

1.8

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

130

1.62

1.26

1.1

1.4

1.20

1.17

mmol/l

1.06

130

(3047007) Chlamydophila sp Ab [Presence] in Serum

787

1.24

1.2

—

(3001729) Color of Synovial fluid

2.00

1.23

2.3

1.4

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

132

1.59

1.20

2.0

1.8

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.00

1.16

1.4

1.0

199.40

188.70

u/ml

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

447

1.30

1.14

1.4

1.2

103.98

104.26

pmol/l

0.02

447

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

166

1.51

1.14

1.1

1.2

800.00

966.67

titre

—

(3022621) pH of Urine by Test strip

488

4489

1.09

1.14

2.9

2.6

5.99

6.06

1.14

325

3058

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

761

1.23

1.12

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.75

1.12

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

200

1.45

1.11

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

143

1.54

1.11

1.2

—

268.57

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

1.78

1.10

1.3

1.1

61.63

56.79

—

(3046861) Legionella sp Ag [Presence] in Urine

2.26

1.10

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.38

1.09

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.73

1.08

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

728

0.78

1.08

1.7

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.87

1.07

1.1

—

(3016038) Potassium [Moles/volume] in Urine

417

1.30

1.07

1.1

1.2

33.35

35.61

mmol/l

0.32

368

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.65

1.06

1.6

1.3

20.50

374.62

u/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

287

1.36

1.06

1.4

1.7

3.66

8.01

nmol/l

0.89

236

(3025018) Bordetella pertussis Ab [Titer] in Serum

374

1.31

1.05

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

148

1712

0.86

1.03

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.27

1.03

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

306

1.34

1.03

10.3

6.2

42.78

11954.68

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.73

1.02

1.1

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.00

1.00

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

2.00

1.00

1.4

1.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

765

1.21

0.98

1.2

1.1

1.25

3.08

1.40

125

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

389

1.29

0.96

1.1

6.64

9.14

iu/ml

0.48

115

(3041918) Cholesterol [Moles/volume] in Pleural fluid

133

1.51

0.94

1.5

1.2

1.36

1.62

mmol/l

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

712

0.80

0.93

1.6

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

516

1.24

0.93

3.3

3.1

118.58

57.10

mg/l

0.52

386

(3023323) Follitropin [Units/volume] in Serum or Plasma

238

2139

1.12

0.92

1.5

1.4

23.35

27.17

iu/l

1.15

195

1802

(3026726) Creatinine [Moles/volume] in Specimen

1.82

0.92

3.5

2.6

520.40

234.96

umol/l

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.82

0.92

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

348

1.30

0.91

1.2

1.1

12.26

9.19

nmol/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.86

0.87

1.4

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

2.00

0.87

1.0

1.1

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

238

1.35

0.85

1.2

1.4

54.68

65.35

0.78

198

(3047189) Immunofixation for 24 hour Urine

299

1.31

0.85

3.0

1.7

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.63

0.84

1.4

1.1

—

(4212803) Bone marrow aspirate examination

1.76

0.83

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

100

854

1.17

0.83

3.4

2.9

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

154

1.43

0.83

1.5

1.9

15.51

52.19

u/l

1.50

144

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

461

1.24

0.83

1.5

1.6

2.57

4.29

ug/l

1.57

399

(3005033) Fetal Nuchal fold Thickness US

700

0.81

0.82

1.6

1.5

1.22

1.28

0.36

498

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.88

0.81

1.2

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

250

1.32

0.79

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.73

0.79

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.82

0.79

1.0

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.82

0.79

1.2

1.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

702

1.18

0.78

1.1

2.25

3.17

eliau/ml

0.62

315

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.78

0.0

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

326

0.74

0.76

1.0

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

0.00

0.76

0.0

1.0

—

91.62

—

(3020650) Glucose [Presence] in Urine

200

1.35

0.76

1.9

1.7

0.00

0.03

estimate

0.80

200

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

209

1.34

0.75

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.84

0.73

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

219

1.33

0.73

2.0

1.9

4.46

2.92

u/ml

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.92

0.70

1.0

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

707

6733

1.06

0.70

5.2

5.0

31.93

32.15

0.19

495

4528

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

186

1.35

0.69

1.3

1.4

102.17

131.10

nmol/l

0.52

135

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.51

0.69

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.51

0.69

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.51

0.69

1.0

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

555

1.19

0.69

3.7

3.5

14.59

12.57

index

0.56

327

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

135

1.41

0.68

1.4

1.3

—

(3010421) pH of Blood

211

1923

1.10

0.68

5.1

4.0

7.41

0.27

206

1906

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.67

0.68

1.0

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

106

929

1.14

0.67

1.6

1.9

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

203

1851

1.10

0.66

1.7

1.8

3.88

4.64

mg/l

0.60

159

1376

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.79

0.66

10.6

8.2

97.40

103.86

g/l

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

241

1.29

0.65

1.9

11.60

380.84

pmol/l

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

848

1.15

0.64

1.3

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

438

0.80

0.64

1.0

839.50

729.01

ng/l

0.77

304

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

606

1.17

0.64

3.2

3.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

542

1.18

0.63

1.3

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

288

1.25

0.62

1.9

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.55

0.62

1.4

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

768

1.15

0.61

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

156

1.35

0.60

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

118

1322

0.89

0.60

4.8

4.1

—

(3003694) ABO and Rh group [Type] in Blood

1647

16047

1.04

0.60

1.5

1.4

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.60

0.0

1.0

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

4.9

—

3.99

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.60

0.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.59

0.0

1.0

—

2.95

—

(4281824) Cell count and differential, peritoneal fluid

542

0.83

0.59

1.1

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

686

1.15

0.59

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

926

0.87

0.57

1.5

65.71

59.57

ug/l

0.52

773

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.67

0.56

1.2

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.67

0.56

2.5

1.5

495.17

320.39

umol/24h

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

440

0.82

0.56

1.0

30.89

41.66

ng/l

1.61

311

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

439

0.82

0.55

1.0

245.57

310.97

ng/l

1.38

316

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

477

1.18

0.54

1.2

297.50

185.93

titre

0.36

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.58

0.54

2.3

3.4

—

(3014891) Appearance of Pleural fluid

1.46

0.54

1.8

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

692

1.14

0.54

1.7

1.8

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

856

0.87

0.53

1.5

1.31

1.14

ratio

0.52

517

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

856

0.87

0.53

1.5

0.93

0.95

ratio

0.27

517

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

856

0.87

0.53

1.5

1.08

1.17

ratio

0.50

519

(3033705) Calcium.ionized [Moles/volume] in Venous blood

653

0.86

0.53

3.0

2.2

1.20

mmol/l

0.07

642

(3036071) Salmonella sp Ab [Titer] in Serum

169

1.30

0.53

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.54

0.53

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.54

0.53

1.7

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.52

0.52

1.6

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

549

5247

1.05

0.52

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.50

0.51

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

161

1.31

0.51

1.0

3.41

11.16

u/ml

2.62

108

(3002523) Influenza virus A Ag [Presence] in Specimen

107

961

1.12

0.50

1.1

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

324

1.20

0.50

4.2

2.3

212.67

199.38

u/l

0.53

318

(3050129) First trimester maternal screen panel - Serum or Plasma

116

1047

1.11

0.50

1.5

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.46

0.50

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.49

0.49

1.0

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.56

0.48

1.7

2.6

0.77

0.64

ug/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

847

0.88

0.47

1.5

—

(1002224) Polysomnography panel

288

2713

1.06

0.47

1.1

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.38

0.45

1.4

2.7

0.70

1.30

mmol/l

—

(3003740) Influenza virus B Ag [Presence] in Specimen

106

959

1.11

0.45

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

591

1.14

0.44

1.4

1.5

65.10

60.56

ug/l

0.30

591

(3039443) Prostate specific Ag panel - Serum or Plasma

113

1239

0.91

0.43

1.5

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

168

1558

1.08

0.43

2.6

2.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

241

0.79

0.43

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

128

0.70

0.43

3.1

3.3

50.44

44.36

—

128

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

128

0.70

0.43

6.2

6.6

10.56

8.12

—

128

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.41

0.43

2.3

1.7

0.14

0.12

nmol/l

0.17

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

104

1.35

0.43

1.2

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.56

0.42

16.0

8.5

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

203

1.23

0.42

1.2

44.43

314.88

ug/l

1.08

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.38

0.41

2.3

1.6

1.20

1.34

umol/l

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.10

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.4

—

119.25

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.40

0.0

1.2

—

37.46

—

(4146454) Self-monitoring of blood glucose

634

1.12

0.40

3.1

2.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

271

0.81

0.40

1.0

1.1

0.63

3.84

u/ml

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.40

0.0

1.0

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.36

0.40

1.2

1.1

0.47

16.28

u/ml

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

232

1.21

0.39

1.3

1.2

9.29

10.06

mm/h

0.17

232

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

269

0.82

0.38

3.4

2.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

524

1.13

0.37

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.39

0.36

2.1

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.36

0.36

1.1

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

671

0.89

0.36

2.9

2.2

4.06

4.07

mmol/l

0.16

660

(3035285) Chloride [Moles/volume] in Venous blood

671

0.89

0.36

2.9

2.2

105.33

105.58

mmol/l

0.15

660

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

144

1.25

0.35

2.6

7.5

71.08

69.86

0.05

118

(40761539) Cells [Type] in Urine sediment by Light microscopy

135

1.26

0.35

1.2

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

140

1307

1.07

0.34

2.9

3.8

451.50

801.34

u/ml

0.49

123

1199

(3001556) Androgen free Index in Serum or Plasma

1.33

0.33

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

472

1.12

0.33

3.5

5.6

164.77

57.37

u/ml

0.59

158

(3014599) Egg white IgE Ab [Units/volume] in Serum

296

0.84

0.32

1.2

1.1

10.22

1.90

u/ml

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

146

1.23

0.32

8.3

7.6

6.78

5.44

kpa

1.08

146

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

110

1.27

0.31

2.9

3.5

94.34

146.67

ng/l

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

124

1157

1.07

0.31

4.5

3.5

30.30

28.56

mg/l

0.18

795

(3005011) Chlamydia sp Ab [Titer] in Serum

1.33

0.30

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.33

0.30

1.7

2.1

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

1.27

0.30

1.3

4.04

4.33

nmol/l

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

234

2232

1.05

0.30

3.1

3.7

1630.58

2698.43

u/ml

0.29

201

1937

(3011288) Drugs identified in Urine by Screen method Nominal

145

1369

1.06

0.27

3.2

3.1

—

(4198724) Urine methamphetamine measurement

224

1.16

0.27

3.3

2.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

141

1.21

0.26

2.8

2.7

45.65

257.83

ug/l

0.52

141

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.20

0.25

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

493

1.10

0.24

1.4

1.3

175.97

187.77

pmol/l

0.19

493

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

212

0.85

0.24

1.6

1.5

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.32

0.23

1.0

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.28

0.23

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

448

1.09

0.22

1.2

360.65

353.15

nmol/l

0.08

377

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.22

0.22

6.2

4.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

388

0.90

0.21

1.1

21.19

19.02

u/ml

0.15

156

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

440

0.91

0.21

1.2

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.21

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.21

0.0

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.21

0.0

2.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

294.23

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.22

0.20

1.8

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.22

0.20

1.0

1.1

8.17

16.45

u/l

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

112

0.80

0.20

6.2

7.6

11.21

10.44

—

112

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.18

0.19

2.5

0.50

0.65

u/field

—

(40758292) HTLV I+II Ab panel - Serum

118

1.19

0.19

1.6

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

206

1991

1.04

0.18

2.4

2.2

—

(3016750) Collection duration of Urine

329

1.09

0.17

2.9

2.1

509.74

489.88

min

0.75

246

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

110

1.18

0.17

1.5

1.3

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.76

0.17

14.0

9.8

0.28

0.21

—

(3028300) Cannabinoids [Presence] in Urine

207

2006

1.03

0.16

2.4

2.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

256

0.90

0.16

1.1

1.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.77

0.15

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

206

1999

1.03

0.15

2.4

2.0

—

(3000330) Specific gravity of Urine by Test strip

281

2881

0.97

0.15

3.9

3.3

1.02

ratio

1.72

259

2612

(40768795) Lymph node Pathology biopsy report

565

0.94

0.15

1.5

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

488

1.07

0.14

1.3

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

117

0.85

0.13

1.1

1.3

—

113.68

titre

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

386

0.93

0.12

1.3

1.5

82.17

85.13

umol/l

0.24

386

(3023430) Cat dander IgE Ab [Units/volume] in Serum

746

1.05

0.12

1.1

4.12

4.29

u/ml

0.03

336

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

648

1.05

0.12

3.6

2.8

13.22

13.17

0.16

642

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

365

1.07

0.12

1.8

1.7

—

(3027944) Amphetamines [Presence] in Urine

202

1972

1.03

0.11

2.5

2.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

808

1.04

0.11

1.0

1.1

2.79

2.86

u/ml

0.03

409

(3020874) Milk IgE Ab [Units/volume] in Serum

301

0.93

0.10

1.0

1.1

35.57

1.58

u/ml

0.45

(3008401) Mugwort IgE Ab [Units/volume] in Serum

973

0.97

0.10

1.1

0.71

1.11

u/ml

0.51

437

(3023410) Appearance of Cerebral spinal fluid

597

0.95

0.10

1.8

1.7

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

780

0.96

0.10

1.6

—

(3044007) Cell count panel - Peritoneal fluid

212

1.09

0.10

1.6

1.9

—

(3019174) dRVVT (LA screen)

1.14

0.10

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.14

0.10

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

238

2335

1.02

0.10

3.1

3.6

101.96

68.14

u/ml

0.24

231

2255

(3017509) Phencyclidine [Presence] in Urine

1.06

0.09

2.8

1.7

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.15

0.09

2.2

2.9

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.04

0.09

1.0

1.1

57.60

93.33

titre

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.09

0.08

1.0

3.22

7.57

u/ml

—

(3025130) Human papilloma virus identified in Specimen

646

1.04

0.08

1.9

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

1.14

0.08

1.3

1.2

66.70

66.48

ug/l

—

(3034426) Prothrombin time (PT)

195

1.08

0.08

1.1

1.3

26.86

28.72

1.42

195

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

205

0.93

0.08

1.5

1.9

8385.71

15729.93

e6/l

—

106

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

702

0.97

0.07

1.0

1.1

0.84

0.35

u/ml

0.36

236

(3020491) Glucose [Moles/volume] in Blood

418

0.96

0.07

2.4

1.9

7.19

6.66

mmol/l

0.50

288

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

294

1.05

0.07

2.5

2.1

16.00

195.94

ug/min

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.06

0.07

1.4

1.3

—

(3016879) Cocaine [Presence] in Urine

188

1850

1.02

0.06

2.5

2.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.85

0.06

2.0

2.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.85

0.06

2.0

—

(44806420) Estimation of glomerular filtration rate

572

1.03

0.06

2.2

2.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1373

13680

1.00

0.05

3.0

3.2

0.71

0.77

ug/l

0.87

893

9010

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

117

1151

1.02

0.04

1.1

2.47

2.22

u/ml

0.08

627

(3043410) Blood group antigens tested for on Red Blood Cells

160

0.94

0.04

1.8

1.9

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

111

1.08

0.04

1.6

2.2

14.67

16.34

umol/l

0.25

111

(3010726) Horse dander IgE Ab [Units/volume] in Serum

925

0.98

0.03

1.1

0.96

1.52

u/ml

0.78

471

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

162

1604

1.01

0.03

1.5

1.6

871.20

999.31

mu/l

1.53

139

1339

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

118

0.93

0.02

1.0

1.2

1.05

167.90

mg/l

—

(40768793) Breast Pathology biopsy report

109

1077

1.01

0.02

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

690

0.99

0.02

1.2

1.3

6.89

7.43

mmol/l

0.78

614

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

419

0.98

0.02

1.3

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

492

1.02

0.01

1.3

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

124

1231

1.01

0.01

3.6

3.2

7.63

7.59

mmol/l

0.05

118

1195

(3041806) Other cells [#/volume] in Blood by Manual count

124

1.05

0.00

1.8

1.5

0.62

0.48

e9/l

0.70

124

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

314

1.02

0.00

4.9

7.1

9.04

117.87

ug/l

0.95

209

(3004775) Volume in Urine collected for unspecified duration

464

1.01

0.00

2.6

2.2

685.97

635.87

0.33

308

(40765089) Chromosome analysis panel - Blood by G-banded

148

1.01

0.00

1.0

—

(40762365) Oxygen content in Arterial blood by calculation

105

0.95

0.00

2.3

3.3

15.12

14.84

ml/dl

—

(3006462) Nitrate [Presence] in Urine

242

0.99

0.00

3.9

3.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

282

0.99

0.00

1.4

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

124

0.97

0.00

1.0

32.82

35.19

iu/ml

0.05

124

(3012494) Peanut IgE Ab [Units/volume] in Serum

136

1.03

0.00

1.1

2.49

8.57

u/ml

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

187

1.02

0.00

1.8

1.4

950.42

347.98

nmol/24h

0.33

187

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

434

0.99

0.00

2.0

1.9

1.52

1.50

u/field

0.01

230

(3003888) Timothy IgE Ab [Units/volume] in Serum

993

1.00

0.00

1.1

4.97

4.71

u/ml

0.07

539

(4133840) Spirometry

149

1.01

0.00

1.4

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

241

1.00

0.00

1.6

2.1

5288.63

3915.95

e6/l

0.09

165

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

7.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.1

—

1577.14

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.3

—

17.23

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

0.00

0.0

4.4

—

2.34

—

(3050794) Legionella sp Ab [Presence] in Serum

1.02

-0.00

1.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.5

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.5

—

0.45

—

(4211845) Urine protein measurement

270

1.00

-0.00

3.7

3.3

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.88

-0.00

1.0

1.2

5.76

6.07

mmol/l

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

-0.00

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.02

-0.00

1.2

5.6

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

170.60

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.89

-0.00

1.2

1.31

1.75

umol/24h

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.02

-0.00

1.0

1.1

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.43

—

(3051101) Glucose [Moles/volume] in Cord blood

1.00

-0.00

1.9

6.8

9.79

8.23

mmol/l

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_DERMATOPHYTOSIS and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_DERMATOPHYTOSIS	1.662 [1.49, 1.85]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 2070 out of 10637 females with AB1_DERMATOPHYTOSIS died.

Males

Parameter	HR [95% CI]	p-value
AB1_DERMATOPHYTOSIS	1.583 [1.43, 1.75]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 3119 out of 13738 males with AB1_DERMATOPHYTOSIS died.

Mortality risk

Mortality risk for people of age

years, who have AB1_DERMATOPHYTOSIS.

N-year risk	Females	Males
1	0.116%	0.267%
5	0.782%	1.751%
10	1.971%	4.39%
15	3.475%	8.116%
20	6.162%	13.442%

Relationships between endpoints

↥

Index endpoint: AB1_DERMATOPHYTOSIS – Dermatophytosis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Dermatophytosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints